Premature obesity-related mortality is caused by cardiovascular and pulmonary diseases, type 2 diabetes mellitus, physical disabilities, osteoarthritis, and certain types of cancer. Obesity is caused by a positive energy balance due to hyper-caloric nutrition, low physical activity, and energy expenditure. Overeating is partially driven by impaired homeostatic feedback of the peripheral energy status in obesity. However, food with its different qualities is a key driver for the reward driven hedonic feeding with tremendous consequences on calorie consumption. In addition to visual and olfactory cues, taste buds of the oral cavity process the earliest signals which affect the regulation of food intake, appetite and satiety. Therefore, taste buds may play a crucial role how food related signals are transmitted to the brain, particularly in priming the body for digestion during the cephalic phase. Indeed, obesity development is associated with a significant reduction in taste buds. Impaired taste bud sensitivity may play a causal role in the pathophysiology of obesity in children and adolescents. In addition, genetic variation in taste receptors has been linked to body weight regulation. This review discusses the importance of taste buds as contributing factors in the development of obesity and how obesity may affect the sense of taste, alterations in food preferences and eating behavior.

Citations

Citations to this article as recorded by  

• Chronic social defeat stress broadly inhibits gene expression in the peripheral taste system and alters taste responses in mice
  Katelyn Tu, Mary Zhou, Jidong J. Tan, Loza Markos, Cameron Cloud, Minliang Zhou, Naoki Hayashi, Nancy E. Rawson, Robert F. Margolskee, Hong Wang
  Physiology & Behavior.2024; 275: 114446.     CrossRef
• Commentary: Is obesity associated with taste alterations? a systematic review
  Marco Alessandrini, Alessandra Vezzoli, Simona Mrakic-Sposta, Sandro Malacrida, Alessandro Micarelli
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• The Obese Taste Bud study: Objectives and study design
  Alexander Kersten, Andrea Lorenz, Cita Nottmeier, Michael Schmidt, Anuschka Roesner, Florian Christoph Richter, Kristin Röhrborn, A. Veronica Witte, Sebastian Hahnel, Till Koehne, Matthias Blüher, Michael Stumvoll, Kerstin Rohde‐Zimmermann, Imke Schamarek
  Diabetes, Obesity and Metabolism.2024;[Epub]     CrossRef
• Testing reward processing models of obesity using in-the-moment assessments of subjective enjoyment of food and non-food activities
  Christina Chwyl, Erica M. LaFata, Sophie R. Abber, Adrienne S. Juarascio, Evan M. Forman
  Eating Behaviors.2023; 48: 101698.     CrossRef
• Taste Function in Adult Humans from Lean Condition to Stage II Obesity: Interactions with Biochemical Regulators, Dietary Habits, and Clinical Aspects
  Alessandro Micarelli, Alessandra Vezzoli, Sandro Malacrida, Beatrice Micarelli, Ilaria Misici, Valentina Carbini, Ilaria Iennaco, Sara Caputo, Simona Mrakic-Sposta, Marco Alessandrini
  Nutrients.2023; 15(5): 1114.     CrossRef
• Exposure to Obesogenic Environments during Perinatal Development Modulates Offspring Energy Balance Pathways in Adipose Tissue and Liver of Rodent Models
  Diana Sousa, Mariana Rocha, Andreia Amaro, Marcos Divino Ferreira-Junior, Keilah Valéria Naves Cavalcante, Tamaeh Monteiro-Alfredo, Cátia Barra, Daniela Rosendo-Silva, Lucas Paulo Jacinto Saavedra, José Magalhães, Armando Caseiro, Paulo Cezar de Freitas M
  Nutrients.2023; 15(5): 1281.     CrossRef
• Exercise modifies fatty acid perception and metabolism
  Deepankumar Shanmugamprema, Karthi Muthuswamy, Vinithra Ponnusamy, Gowtham Subramanian, Keerthana Vasanthakumar, Vasanth Krishnan, Selvakumar Subramaniam
  Acta Physiologica.2023;[Epub]     CrossRef
• The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception
  Imke Schamarek, Lars Anders, Rima M. Chakaroun, Peter Kovacs, Kerstin Rohde-Zimmermann
  Nutrition Journal.2023;[Epub]     CrossRef
• Smell, taste and food habits changes along body mass index increase: an observational study
  Alessandro Micarelli, Sandro Malacrida, Alessandra Vezzoli, Beatrice Micarelli, Ilaria Misici, Valentina Carbini, Sara Caputo, Simona Mrakic-Sposta, Marco Alessandrini
  European Archives of Oto-Rhino-Laryngology.2023; 280(12): 5595.     CrossRef
• Sweet-inhibiting effects of gurmarin on intake during repeated acute and long-term sugar exposure: A behavioural analysis using an animal model
  Raquel Rayo-Morales, Antonio Segura-Carretero, Nicolas Poirier, Loïc Briand, David Garcia-Burgos
  Journal of Functional Foods.2023; 108: 105743.     CrossRef
• Suppression of sweet taste-related responses by plant-derived bioactive compounds and eating. Part I: A systematic review in humans
  Raquel Rayo-Morales, Antonio Segura-Carretero, Isabel Borras-Linares, David Garcia-Burgos
  Heliyon.2023; 9(10): e19733.     CrossRef
• The oral microbial odyssey influencing chronic metabolic disease
  Upasana Gupta, Priyankar Dey
  Archives of Physiology and Biochemistry.2023; : 1.     CrossRef
• Taste of Fat and Obesity: Different Hypotheses and Our Point of View
  Laurent Brondel, Didier Quilliot, Thomas Mouillot, Naim Akhtar Khan, Philip Bastable, Vincent Boggio, Corinne Leloup, Luc Pénicaud
  Nutrients.2022; 14(3): 555.     CrossRef
• Effect of Obesity Surgery on Taste
  Alhanouf S. Al-Alsheikh, Shahd Alabdulkader, Brett Johnson, Anthony P. Goldstone, Alexander Dimitri Miras
  Nutrients.2022; 14(4): 866.     CrossRef
• Oral motor function in obesity
  Mariana Cristina Zanin Castro, Carla Manfredi dos Santos, Raquel Eduardo Lucas, Claudia Maria de Felício, Roberto Oliveira Dantas
  Journal of Oral Rehabilitation.2022; 49(5): 529.     CrossRef
• The Effect of Artificial Sweeteners Use on Sweet Taste Perception and Weight Loss Efficacy: A Review
  Klara Wilk, Wiktoria Korytek, Marta Pelczyńska, Małgorzata Moszak, Paweł Bogdański
  Nutrients.2022; 14(6): 1261.     CrossRef
• Effects of visual and aromatic stimulations on the perception of five fundamental tastes
  Mayu Itoh, Aya Kitagawa, Harumi Ouchi, Mana Yamaguchi, Ran Watanabe, Hideyuki Sone, Shin Kamiyama
  Bioscience, Biotechnology, and Biochemistry.2022; 86(5): 655.     CrossRef
• Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
  Kristine Eidal Tanem, Einar Stensvold, Petter Wilberg, Anne B. Skaare, Preet Bano Singh, Petter Brandal, Bente Brokstad Herlofson
  Supportive Care in Cancer.2022; 30(7): 6155.     CrossRef
• Changes in Food Choice, Taste, Desire, and Enjoyment 1 Year after Sleeve Gastrectomy: A Prospective Study
  Luigi Schiavo, Silvana Mirella Aliberti, Pietro Calabrese, Anna Maria Senatore, Lucia Severino, Gerardo Sarno, Antonio Iannelli, Vincenzo Pilone
  Nutrients.2022; 14(10): 2060.     CrossRef
• Characterizing Adolescents' Dietary Intake by Taste: Results From the UK National Diet and Nutrition Survey
  Areej Bawajeeh, Michael A. Zulyniak, Charlotte E. L. Evans, Janet E. Cade
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception’s and Reduces Bitter-Induced Pleasantness in Severe Obesity
  Sara Rurgo, Elena Cantone, Marcella Pesce, Eleonora Efficie, Mario Musella, Barbara Polese, Barbara De Conno, Marta Pagliaro, Luisa Seguella, Bruna Guida, Giuseppe Esposito, Giovanni Sarnelli
  Journal of Clinical Medicine.2022; 11(14): 3957.     CrossRef
• Genetic variation in sweet taste receptors and a mechanistic perspective on sweet and fat taste sensation in the context of obesity
  Vinithra Ponnusamy, Gowtham Subramanian, Karthi Muthuswamy, Deepankumar Shanmugamprema, Vasanth Krishnan, Thirunavukkarasu Velusamy, Selvakumar Subramaniam
  Obesity Reviews.2022;[Epub]     CrossRef
• Applying a systems perspective to understand the mechanisms of the European School Fruit and Vegetable Scheme
  Mahshid Zolfaghari, Biljana Meshkovska, Anna Banik, Carlijn B M Kamphuis, Birgit Kopainsky, Aleksandra Luszczynska, Celine Murrin, Nanna Lien
  European Journal of Public Health.2022; 32(Supplement): iv107.     CrossRef
• Self-Reported Sensory Decline in Older Adults Is Longitudinally Associated With Both Modality-General and Modality-Specific Factors
  Alan O’ Dowd, Rebecca J Hirst, Annalisa Setti, Rose Anne Kenny, Fiona N Newell, Nancy W Glynn
  Innovation in Aging.2022;[Epub]     CrossRef
• The sweet taste receptor, glucose transporters, and the ATP-sensitive K+ (KATP) channel: sugar sensing for the regulation of energy homeostasis
  Ryusuke Yoshida, Keiko Yasumatsu, Yuzo Ninomiya
  Current Opinion in Physiology.2021; 20: 57.     CrossRef
• Gustatory Function Can Improve after Multimodal Lifestyle Intervention: A Longitudinal Observational Study in Pediatric Patients with Obesity
  Laura Kalveram, Jacob Gohlisch, Jana Brauchmann, Johanna Overberg, Peter Kühnen, Susanna Wiegand
  Childhood Obesity.2021; 17(2): 136.     CrossRef
• Single nucleotide polymorphism in CD36: Correlation to peptide YY levels in obese and non-obese adults
  Muthuswamy Karthi, Shanmugamprema Deepankumar, Ponnusamy Vinithra, Subramanian Gowtham, Krishnan Vasanth, Palanivelu Praveen Raj, Rajasekaran Senthilkumar, Subramaniam Selvakumar
  Clinical Nutrition.2021; 40(5): 2707.     CrossRef
• Lezzet Algısının Oluşmasında Çevresel ve Genetik Faktörlerin Etkileri
  Mücahit MUSLU, Gülden Fatma GÖKÇAY
  Batı Karadeniz Tıp Dergisi.2021; 5(1): 7.     CrossRef
• Food Preferences and Obesity
  Sara Spinelli, Erminio Monteleone
  Endocrinology and Metabolism.2021; 36(2): 209.     CrossRef
• Western Diet Induced Remodelling of the Tongue Proteome
  Mriga Dutt, Yaan-Kit Ng, Jeffrey Molendijk, Hamzeh Karimkhanloo, Luoping Liao, Ronnie Blazev, Magdalene K. Montgomery, Matthew J. Watt, Benjamin L. Parker
  Proteomes.2021; 9(2): 22.     CrossRef
• Obesity-induced taste dysfunction, and its implications for dietary intake
  Fiona Harnischfeger, Robin Dando
  International Journal of Obesity.2021; 45(8): 1644.     CrossRef
• Recent Advances in Understanding Peripheral Taste Decoding I: 2010 to 2020
  Jea Hwa Jang, Obin Kwon, Seok Jun Moon, Yong Taek Jeong
  Endocrinology and Metabolism.2021; 36(3): 469.     CrossRef
• Smash of diabetes mellitus on smile
  Farhana Akter, Mainul Haque
  Advances in Human Biology.2021; 11(3): 273.     CrossRef
• Perception des acides gras et potentiels évoqués gustatifs : application dans l’obésité
  Thomas Mouillot, Laurent Brondel, Agnès Jacquin-Piques
  Cahiers de Nutrition et de Diététique.2021; 56(5): 280.     CrossRef
• Trastornos del gusto como indicador de enfermedad sistémica
  Karla Ivohnne Pedraza Maquera, Caroll Johana Uberlinda Lévano Villanueva
  Revista Odontológica Basadrina.2021; 5(2): 52.     CrossRef

Impaired β-cell function is the key pathophysiology of type 2 diabetes mellitus, and chronic exposure of nutrient excess could lead to this tragedy. For preserving β-cell function, it is essential to understand the cause and mechanisms about the progression of β-cells failure. Glucotoxicity, lipotoxicity, and glucolipotoxicity have been suggested to be a major cause of β-cell dysfunction for decades, but not yet fully understood. Fatty acid translocase cluster determinant 36 (CD36), which is part of the free fatty acid (FFA) transporter system, has been identified in several tissues such as muscle, liver, and insulin-producing cells. Several studies have reported that induction of CD36 increases uptake of FFA in several cells, suggesting the functional interplay between glucose and FFA in terms of insulin secretion and oxidative metabolism. However, we do not currently know the regulating mechanism and physiological role of CD36 on glucolipotoxicity in pancreatic β-cells. Also, the downstream and upstream targets of CD36 related signaling have not been defined. In the present review, we will focus on the expression and function of CD36 related signaling in the pancreatic β-cells in response to hyperglycemia and hyperlipidemia (ceramide) along with the clinical studies on the association between CD36 and metabolic disorders.

Citations

Citations to this article as recorded by  

• Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
  Alpana Mukhuty, Samanwita Mandal, Chandrani Fouzder, Snehasis Das, Dipanjan Chattopadhyay, Tanmay Majumdar, Rakesh Kundu
  Molecular and Cellular Endocrinology.2024; 581: 112112.     CrossRef
• CD36 gene variant rs1761667(G/A) as a biomarker in obese type 2 diabetes mellitus cases
  Ashwin Kumar Shukla, Amreen Shamsad, Atar Singh Kushwah, Shalini Singh, Kauser Usman, Monisha Banerjee
  Egyptian Journal of Medical Human Genetics.2024;[Epub]     CrossRef
• CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis
  Xiang Zhang, Catherine King, Alexander Dowell, Paul Moss, Lorraine Harper, Dimitrios Chanouzas, Xiong-zhong Ruan, Alan David Salama
  Clinical Immunology.2024; 260: 109914.     CrossRef
• The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target
  Yun Li, Yaxi Chen, Xiong Z. Ruan
  Pediatric Discovery.2023;[Epub]     CrossRef
• The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?
  Christina Clavelo‐Farrow, Patricia Thomas
  Diabetic Medicine.2023;[Epub]     CrossRef
• SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
  Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding, Zhiqiang Yin, Shan Li, Zhengxia Wang, Lianzheng Zhou, Xueqin Chen, Yuan Ma, Jinhai Tang, Yun Liu, Liang Liu, Mao Huang
  Emerging Microbes & Infections.2022; 11(1): 1115.     CrossRef
• Is imaging-based muscle quantity associated with risk of diabetes? A meta-analysis of cohort studies
  Shanhu Qiu, Xue Cai, Yang Yuan, Bo Xie, Zilin Sun, Tongzhi Wu
  Diabetes Research and Clinical Practice.2022; 189: 109939.     CrossRef
• Lipotoxicity in a Vicious Cycle of Pancreatic Beta Cell Exhaustion
  Vladimir Grubelnik, Jan Zmazek, Matej Završnik, Marko Marhl
  Biomedicines.2022; 10(7): 1627.     CrossRef
• Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus
  Xixiang Wang, Xiaojun Ma, Jingjing Xu, Yujie Guo, Shaobo Zhou, Huiyan Yu, Linhong Yuan
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
  Noorzaileen Eileena Zaidi, Nur Aima Hafiza Shazali, Thean-Chor Leow, Mohd Azuraidi Osman, Kamariah Ibrahim, Wan-Hee Cheng, Kok-Song Lai, Nik Mohd Afizan Nik Abd Rahman
  Cells.2022; 11(22): 3556.     CrossRef
• The Past and Present Lives of the Intraocular Transmembrane Protein CD36
  Rucui Yang, Qingping Liu, Mingzhi Zhang
  Cells.2022; 12(1): 171.     CrossRef
• Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
  Sachin Kumar, Tapan Behl, Monika Sachdeva, Aayush Sehgal, Shilpa Kumari, Arun Kumar, Gagandeep Kaur, Harlokesh Narayan Yadav, Simona Bungau
  Life Sciences.2021; 264: 118661.     CrossRef
• Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican mestizos with type-2 diabetes from western Mexico
  Beatriz Teresita Martín-Márquez, Flavio Sandoval-Garcia, Mónica Vazquez-Del Mercado, Erika-Aurora Martínez-García, Fernanda-Isadora Corona-Meraz, Ana-Lilia Fletes-Rayas, Soraya-Amalí Zavaleta-Muñiz
  Nutrición Hospitalaria.2021;[Epub]     CrossRef
• Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis
  Ma’mon M. Hatmal, Walhan Alshaer, Ismail S. Mahmoud, Mohammad A. I. Al-Hatamleh, Hamzeh J. Al-Ameer, Omar Abuyaman, Malek Zihlif, Rohimah Mohamud, Mais Darras, Mohammad Al Shhab, Rand Abu-Raideh, Hilweh Ismail, Ali Al-Hamadi, Ali Abdelhay, Kanhaiya Singh
  PLOS ONE.2021; 16(10): e0257857.     CrossRef
• Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
  Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan
  Membranes.2021; 11(11): 844.     CrossRef

Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying drugs. Their main effects are reduction of triglycerides and increase in high-density lipoprotein levels. Several randomized controlled trials have not demonstrated their benefits on cardiovascular risk reduction, especially as an “add on” to statin therapy. However, subsequent analyses by major clinical trials, meta-analyses, and real-world evidence have proposed their potential in specific patient populations with atherogenic dyslipidemia and metabolic syndrome. Here, we have reviewed and discussed the accumulated data on fibrates to understand their current status in cardiovascular risk management.

Citations

Citations to this article as recorded by  

• Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
  Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118.     CrossRef
• Role of PPARα in inflammatory response of C2C12 myotubes
  Yuki Shimizu, Keiko Hamada, Tingting Guo, Chie Hasegawa, Yusuke Kuga, Katsushi Takeda, Takashi Yagi, Hiroyuki Koyama, Hiroshi Takagi, Daisuke Aotani, Hiromi Kataoka, Tomohiro Tanaka
  Biochemical and Biophysical Research Communications.2024; 694: 149413.     CrossRef
• Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
  John J. P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson
  Current Atherosclerosis Reports.2024; 26(2): 35.     CrossRef
• Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
  Virginia Actis Dato, Stephan Lange, Yoshitake Cho
  International Journal of Molecular Sciences.2024; 25(2): 1211.     CrossRef
• ApoB100 and Atherosclerosis: What’s New in the 21st Century?
  Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Maria Dalamaga
  Metabolites.2024; 14(2): 123.     CrossRef
• Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population
  N. Ponce-Ruíz, J. F. Herrera-Moreno, A. E. Rojas-García, B. S. Barrón-Vivanco, C. A. González-Arias, Y. Y. Bernal-Hernández, L. Ortega-Cervantes, J. Ponce-Gallegos, J. A. Hernández-Nolasco, I. M. Medina-Díaz
  Heart and Vessels.2024;[Epub]     CrossRef
• Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
  Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
  Diabetes & Metabolism Journal.2024; 48(2): 184.     CrossRef
• Coenzyme Q10 in atherosclerosis
  Minjun Liao, Xueke He, Yangyang Zhou, Weiqiang Peng, Xiao-Mei Zhao, Miao Jiang
  European Journal of Pharmacology.2024; 970: 176481.     CrossRef
• Present and Future of Dyslipidaemia Treatment—A Review
  Iveta Merćep, Andro Vujević, Dominik Strikić, Ivana Radman, Ivan Pećin, Željko Reiner
  Journal of Clinical Medicine.2023; 12(18): 5839.     CrossRef
• VLDL receptor gene therapy for reducing atherogenic lipoproteins
  Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, Ray Tabibiazar
  Molecular Metabolism.2023; 69: 101685.     CrossRef
• The emerging role of PPAR-alpha in breast cancer
  Zhiwen Qian, Lingyan Chen, Jiayu Liu, Ying Jiang, Yan Zhang
  Biomedicine & Pharmacotherapy.2023; 161: 114420.     CrossRef
• Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease
  Yujie Pu, Chak Kwong Cheng, Hongsong Zhang, Jiang‐Yun Luo, Li Wang, Brian Tomlinson, Yu Huang
  Medicinal Research Reviews.2023; 43(6): 2086.     CrossRef
• Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
  DuoYao Cao, Zakir Khan, Xiaomo Li, Suguru Saito, Ellen A Bernstein, Aaron R Victor, Faizan Ahmed, Aoi O Hoshi, Luciana C Veiras, Tomohiro Shibata, Mingtian Che, Lei Cai, Michifumi Yamashita, Ryan E Temel, Jorge F Giani, Daniel J Luthringer, Ajit S Divakar
  Cardiovascular Research.2023; 119(9): 1825.     CrossRef
• Rapid flow synthesis of fenofibrate via scalable flash chemistry with in-line Li recovery
  Sanket A. Kawale, Dong-Chang Kang, Gwang-Noh Ahn, Amirreza Mottafegh, Ji-Ho Kang, Gi-Su Na, Dong-Pyo Kim
  Chemical Engineering Journal.2023; 477: 147033.     CrossRef
• Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
  Marat V. Ezhov, Gregory P. Arutyunov
  Diseases.2023; 11(4): 140.     CrossRef
• Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
  Giulio Preta
  Cells.2023; 12(20): 2466.     CrossRef
• Exploring the hypolipidemic effects of bergenin from Saxifraga melanocentra Franch: mechanistic insights and potential for hyperlipidemia treatment
  Li Zhang, Yingying Tong, Yan Fang, Jinjin Pei, Qilan Wang, Gang Li
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Obesity and Dyslipidemia
  Barbora Nussbaumerova, Hana Rosolova
  Current Atherosclerosis Reports.2023; 25(12): 947.     CrossRef
• Bibliometric analysis of residual cardiovascular risk: trends and frontiers
  Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
  Journal of Health, Population and Nutrition.2023;[Epub]     CrossRef
• Hypertriglyceridemia in Apoa5–/– mice results from reduced amounts of lipoprotein lipase in the capillary lumen
  Ye Yang, Anne P. Beigneux, Wenxin Song, Le Phuong Nguyen, Hyesoo Jung, Yiping Tu, Thomas A. Weston, Caitlyn M. Tran, Katherine Xie, Rachel G. Yu, Anh P. Tran, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Yan Q. Chen, Eugene Y. Zhen, Joonyoung R.
  Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
  Dipali Kale, Amol Fatangare, Prasad Phapale, Albert Sickmann
  Cells.2023; 12(24): 2796.     CrossRef
• Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
  Gary F Lewis, Robert A Hegele
  The Lancet Diabetes & Endocrinology.2022; 10(2): 142.     CrossRef
• Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
  Thomas Metzner, Deborah R. Leitner, Karin Mellitzer, Andrea Beck, Harald Sourij, Tatjana Stojakovic, Gernot Reishofer, Winfried März, Ulf Landmesser, Hubert Scharnagl, Hermann Toplak, Günther Silbernagel
  Biomedicines.2022; 10(1): 193.     CrossRef
• Is there a role of lipid-lowering therapies in the management of fatty liver disease?
  Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos
  World Journal of Hepatology.2022; 14(1): 119.     CrossRef
• Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
  Ana Clara Aprotosoaie, Alexandru-Dan Costache, Irina-Iuliana Costache
  Pharmaceutics.2022; 14(4): 722.     CrossRef
• The Overlooked Transformation Mechanisms of VLCFAs: Peroxisomal β-Oxidation
  Qinyue Lu, Weicheng Zong, Mingyixing Zhang, Zhi Chen, Zhangping Yang
  Agriculture.2022; 12(7): 947.     CrossRef
• Current Trends of Big Data Research Using the Korean National Health Information Database
  Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
  Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
• New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
  Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(4): 517.     CrossRef
• Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
  Agata Jedrzejewska, Alicja Braczko, Ada Kawecka, Marcin Hellmann, Piotr Siondalski, Ewa Slominska, Barbara Kutryb-Zajac, Magdi H. Yacoub, Ryszard T. Smolenski
  International Journal of Molecular Sciences.2022; 23(17): 9886.     CrossRef
• Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
  Joon Ho Moon, Kyuho Kim, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef
• Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
  Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Metabolism.2022; 137: 155327.     CrossRef
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
  Veronika Vyletelová, Mária Nováková, Ľudmila Pašková
  Pharmaceuticals.2022; 15(10): 1278.     CrossRef
• Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data
  Cristina Gavina, Daniel Seabra Carvalho, Marisa Pardal, Marta Afonso-Silva, Diana Grangeia, Ricardo Jorge Dinis-Oliveira, Francisco Araújo, Tiago Taveira-Gomes
  Journal of Clinical Medicine.2022; 11(22): 6825.     CrossRef
• New and emerging lipid-lowering therapy
  James M Backes, Daniel E Hilleman
  Future Cardiology.2021; 17(8): 1407.     CrossRef
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
  Styliani Fragki, Hubert Dirven, Tony Fletcher, Bettina Grasl-Kraupp, Kristine Bjerve Gützkow, Ron Hoogenboom, Sander Kersten, Birgitte Lindeman, Jochem Louisse, Ad Peijnenburg, Aldert H. Piersma, Hans M. G. Princen, Maria Uhl, Joost Westerhout, Marco J. Z
  Critical Reviews in Toxicology.2021; 51(2): 141.     CrossRef
• A network pharmacology analysis on drug‐like compounds from Ganoderma lucidum for alleviation of atherosclerosis
  Ki Kwang Oh, Md. Adnan, Dong Ha Cho
  Journal of Food Biochemistry.2021;[Epub]     CrossRef
• Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
  Myung Soo Park, Jong-Chan Youn, Eung Ju Kim, Ki Hoon Han, Sang Hak Lee, Sung Hea Kim, Byung Jin Kim, Sung Uk Kwon, Kyu-Hyung Ryu
  Clinical Therapeutics.2021; 43(10): 1735.     CrossRef
• Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
  Louis Jacob, Roger-Axel Greiner, Mark Luedde, Karel Kostev
  Journal of Cardiovascular Pharmacology.2021; 78(6): 885.     CrossRef
• Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
  Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
  Advances in Therapy.2020; 37(8): 3450.     CrossRef
• Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats
  Corbin A. Shields, Bibek Poudel, Kasi C. McPherson, Andrea K. Brown, Ubong S. Ekperikpe, Evan Browning, Lamari Sutton, Denise C. Cornelius, Jan M. Williams
  Frontiers in Physiology.2020;[Epub]     CrossRef
• Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
  Amelia Charlton, Jessica Garzarella, Karin A. M. Jandeleit-Dahm, Jay C. Jha
  Biology.2020; 10(1): 18.     CrossRef

As a member of the class IIa histone deacetylases (HDACs), HDAC9 catalyzes the deacetylation of histones and transcription factors, commonly leading to the suppression of gene transcription. The activity of HDAC9 is regulated transcriptionally and post-translationally. HDAC9 is known to play an essential role in regulating myocyte and adipocyte differentiation and cardiac muscle development. Also, recent studies have suggested that HDAC9 is involved in the pathogenesis of chronic diseases, including cardiovascular diseases, osteoporosis, autoimmune disease, cancer, obesity, insulin resistance, and liver fibrosis. HDAC9 modulates the expression of genes related to the pathogenesis of chronic diseases by altering chromatin structure in their promotor region or reducing the transcriptional activity of their respective transcription factors. This review summarizes the current knowledge of the regulation of HDAC9 expression and activity. Also, the roles of HDAC9 in the pathogenesis of chronic diseases are discussed, along with potential underlying mechanisms.

Citations

Citations to this article as recorded by  

• Impact of housing temperature on adipose tissue HDAC9 expression and adipogenic differentiation in high fat‐fed mice
  Samah Ahmadieh, Brandee Goo, Abdalrahman Zarzour, David Kim, Hong Shi, Praneet Veerapaneni, Ronnie Chouhaita, Nicole K. H. Yiew, Carla Dominguez Gonzalez, Akash Chakravartty, James Pennoyer, Nazeera Hassan, Tyler W. Benson, Mourad Ogbi, David J. Fulton, R
  Obesity.2024; 32(1): 107.     CrossRef
• HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD
  Guixian Zheng, Chao Li, Xiaoli Chen, Zhaohui Deng, Ting Xie, Zengyu Huo, Xinyan Wei, Yanbing Huang, Xia Zeng, Yu Luo, Jing Bai
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(3): 167023.     CrossRef
• Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes
  Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
  Scientific Reports.2024;[Epub]     CrossRef
• HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
  Totan Das, Samima Khatun, Tarun Jha, Shovanlal Gayen
  Mini-Reviews in Medicinal Chemistry.2024; 24(7): 767.     CrossRef
• Targeting histone deacetylases for cancer therapy: Trends and challenges
  Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
  Acta Pharmaceutica Sinica B.2023; 13(6): 2425.     CrossRef
• Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
  Guokai Zhang, Zhenying Liu, Zihan Li, Bing Zhang, Pengyu Yao, Yun Qiao
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Research Progress on Histone Deacetylase Inhibitors
  玉姜 汤
  Hans Journal of Medicinal Chemistry.2023; 11(02): 116.     CrossRef
• HDAC9 Inhibition as a Novel Treatment for Stroke
  Hugh S. Markus
  Stroke.2023; 54(12): 3182.     CrossRef
• Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
  Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
  Pharmacological Research.2023; 198: 107009.     CrossRef
• Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration
  Ming Lei, Hui Lin, Deyao Shi, Pan Hong, Hui Song, Bomansaan Herman, Zhiwei Liao, Cao Yang
  Cellular & Molecular Biology Letters.2023;[Epub]     CrossRef
• Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
  Sylvia Fong, Bridget Yates, Choong-Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, Adebayo Lawal, Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, K. John Pasi, Wing Yen Wong
  Nature Medicine.2022; 28(4): 789.     CrossRef
• Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
  Michael Hauke, Robert Eckenstaler, Anne Ripperger, Anna Ender, Heike Braun, Ralf A. Benndorf
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
  Long Xu, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, Jing Su
  Biomedicines.2022; 10(2): 374.     CrossRef
• Common protein-coding variants influence the racing phenotype in galloping racehorse breeds
  Haige Han, Beatrice A. McGivney, Lucy Allen, Dongyi Bai, Leanne R. Corduff, Gantulga Davaakhuu, Jargalsaikhan Davaasambuu, Dulguun Dorjgotov, Thomas J. Hall, Andrew J. Hemmings, Amy R. Holtby, Tuyatsetseg Jambal, Badarch Jargalsaikhan, Uyasakh Jargalsaikh
  Communications Biology.2022;[Epub]     CrossRef
• Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
  Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi
  Neurological Sciences.2021; 42(3): 951.     CrossRef
• Emerging roles of SIRT6 in human diseases and its modulators
  Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou
  Medicinal Research Reviews.2021; 41(2): 1089.     CrossRef
• Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
  Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
  Life.2021; 11(2): 90.     CrossRef
• circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis
  Huan Wan, Ting You, Wei Luo
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
  Chun Yang, Stéphane Croteau, Pierre Hardy
  Cellular Oncology.2021; 44(5): 997.     CrossRef
• Dual HDAC/BRD4 inhibitors against cancer
  Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
  Medicinal Chemistry Research.2021; 30(10): 1822.     CrossRef
• miR‐211‐5p is down‐regulated and a prognostic marker in bladder cancer
  Weisheng Wang, Zhiming Liu, Xuegang Zhang, Junning Liu, Junqing Gui, Maorong Cui, Yong Li
  The Journal of Gene Medicine.2020;[Epub]     CrossRef

Cyclic adenosine monophosphate (cAMP) signaling is critical for regulating metabolic homeostasis in mammals. In particular, transcriptional regulation by cAMP response element-binding protein (CREB) and its coactivator, CREB-regulated transcription coactivator (CRTC), is essential for controlling the expression of critical enzymes in the metabolic process, leading to more chronic changes in metabolic flux. Among the CRTC isoforms, CRTC2 is predominantly expressed in peripheral tissues and has been shown to be associated with various metabolic pathways in tissue-specific manners. While initial reports showed the physiological role of CRTC2 in regulating gluconeogenesis in the liver, recent studies have further delineated the role of this transcriptional coactivator in the regulation of glucose and lipid metabolism in various tissues, including the liver, pancreatic islets, endocrine tissues of the small intestines, and adipose tissues. In this review, we discuss recent studies that have utilized knockout mouse models to delineate the role of CRTC2 in the regulation of metabolic homeostasis.

Citations

Citations to this article as recorded by  

• Integration of genomic and transcriptomic data of inbred mouse models for polygenic obesity and leanness revealed “obese” and “lean” candidate alleles in polyadenylation signals
  Martin Šimon, Špela Mikec, Nicholas M. Morton, Santosh S. Atanur, Simon Horvat, Tanja Kunej
  Gene Reports.2024; 35: 101903.     CrossRef
• Mylabris phalerata induces the apoptosis and cell cycle delay in HCC, and potentiates the effect of sorafenib based on the molecular and network pharmacology approach
  Young Woo Kim, Seon Been Bak, Su Youn Baek, Il Kon Kim, Won-Yung Lee, Un-Jung Yun, Kwang-Il Park
  Molecular & Cellular Toxicology.2023; 19(4): 731.     CrossRef
• Emerging Role of SMILE in Liver Metabolism
  Nanthini Sadasivam, Kamalakannan Radhakrishnan, Hueng-Sik Choi, Don-Kyu Kim
  International Journal of Molecular Sciences.2023; 24(3): 2907.     CrossRef
• PIMT regulates hepatic gluconeogenesis in mice
  Bandish Kapadia, Soma Behera, Sireesh T. Kumar, Tapan Shah, Rebecca Kristina Edwin, Phanithi Prakash Babu, Partha Chakrabarti, Kishore V.L. Parsa, Parimal Misra
  iScience.2023; 26(3): 106120.     CrossRef
• Biological functions of CRTC2 and its role in metabolism-related diseases
  Hong-Yu Zheng, Yan-Xia Wang, Kun Zhou, Hai-Lin Xie, Zhong Ren, Hui-Ting Liu, Yang-Shao Ou, Zhi-Xiang Zhou, Zhi-Sheng Jiang
  Journal of Cell Communication and Signaling.2023; 17(3): 495.     CrossRef
• An insulin-regulated arrestin domain protein controls hepatic glucagon action
  Sezin Dagdeviren, Megan F. Hoang, Mohsen Sarikhani, Vanessa Meier, Jake C. Benoit, Marinna C. Okawa, Veronika Y. Melnik, Elisabeth M. Ricci-Blair, Natalie Foot, Randall H. Friedline, Xiaodi Hu, Lauren A. Tauer, Arvind Srinivasan, Maxim B. Prigozhin, Sudha
  Journal of Biological Chemistry.2023; 299(8): 105045.     CrossRef
• The Pleiotropic Face of CREB Family Transcription Factors
  Md. Arifur Rahman Chowdhury, Jungeun An, Sangyun Jeong
  Molecules and Cells.2023; 46(7): 399.     CrossRef
• It is a branched road to adipose tissue aging
  N. Touitou, B. Lerrer, H. Y. Cohen
  Nature Aging.2023; 3(8): 911.     CrossRef
• Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement
  Hye-Sook Han, Eunyong Ahn, Eun Seo Park, Tom Huh, Seri Choi, Yongmin Kwon, Byeong Hun Choi, Jueun Lee, Yoon Ha Choi, Yujin L. Jeong, Gwang Bin Lee, Minji Kim, Je Kyung Seong, Hyun Mu Shin, Hang-Rae Kim, Myeong Hee Moon, Jong Kyoung Kim, Geum-Sook Hwang, S
  Nature Aging.2023; 3(8): 982.     CrossRef
• Exploring the diagnostic value, prognostic value, and biological functions of NPC gene family members in hepatocellular carcinoma based on a multi-omics analysis
  Keheng Chen, Xin Zhang, Huixin Peng, Fengdie Huang, Guangyu Sun, Qijiang Xu, Lusheng Liao, Zhiyong Xing, Yanping Zhong, Zhichao Fang, Meihua Liao, Shihua Luo, Wencheng Chen, Mingyou Dong
  Functional & Integrative Genomics.2023;[Epub]     CrossRef
• MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
  Hao Sun, Jongsook Kim Kemper
  Experimental & Molecular Medicine.2023; 55(9): 1974.     CrossRef
• Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice
  Miaomiao Du, Xueyun Li, Fangyi Xiao, Yinxu Fu, Yu Shi, Sihan Guo, Lifang Chen, Lu Shen, Lan Wang, Huang Cheng, Hao Li, Anran Xie, Yaping Zhou, Kaiqiang Yang, Hezhi Fang, Jianxin Lyu, Qiongya Zhao
  Metabolism.2022; 134: 155244.     CrossRef
• cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
  Muhammad Bilal Ahmed, Abdullah A. A. Alghamdi, Salman Ul Islam, Joon-Seok Lee, Young-Sup Lee
  Cells.2022; 11(13): 2020.     CrossRef
• Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity
  Aijun Qiao, Wenxia Ma, Ying Jiang, Chaoshan Han, Baolong Yan, Junlan Zhou, Gangjian Qin
  International Journal of Molecular Sciences.2022; 23(19): 11469.     CrossRef
• The Role of Small Heterodimer Partner-Interacting Leucine Zipper (SMILE) as a Transcriptional Corepressor in Hepatic Glucose and Lipid Metabolism
  Woo-Ram Park, Byungyoon Choi, Nanthini Sadasivam, Don-Kyu Kim
  Trends in Agriculture & Life Sciences.2022; 60: 7.     CrossRef
• AMPK Localization: A Key to Differential Energy Regulation
  Qonita Afinanisa, Min Kyung Cho, Hyun-A Seong
  International Journal of Molecular Sciences.2021; 22(20): 10921.     CrossRef

The safety of metformin use for patients with type 2 diabetes mellitus (T2DM) and advanced kidney disease is controversial, and more recent guidelines have suggested that metformin be used cautiously in this group until more definitive evidence concerning its safety is available. The Korean Diabetes Association and the Korean Society of Nephrology have agreed on consensus statements concerning metformin use for patients with T2DM and renal dysfunction, particularly when these patients undergo imaging studies using iodinated contrast media (ICM). Metformin can be used safely when the estimated glomerular filtration rate (eGFR) is ≥45 mL/min/1.73 m². If the eGFR is between 30 and 44 mL/min/1.73 m², metformin treatment should not be started. If metformin is already in use, a daily dose of ≤1,000 mg is recommended. Metformin is contraindicated when the eGFR is <30 mL/min/1.73 m². Renal function should be evaluated prior to any ICM-related procedures. During procedures involving intravenous administration of ICM, metformin should be discontinued starting the day of the procedures and up to 48 hours post-procedures if the eGFR is <60 mL/min/1.73 m².

Citations

Citations to this article as recorded by  

• Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study
  Wonjoon Jeong, Jung Sunwoo, Yeonho You, Jung Soo Park, Jin Hong Min, Yong Nam In, Hong Joon Ahn, So Young Jeon, Jang Hee Hong, Ji Hye Song, Hyein Kang, My Tuyen Thi Nguyen, Jaehan Kim, Changshin Kang
  Scientific Reports.2024;[Epub]     CrossRef
• Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication
  Alisher Ikramov, Shakhnoza Mukhtarova, Raisa Trigulova, Dilnoza Alimova, Saodat Abdullaeva
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Determinants of vitamin B12 deficiency in patients with type-2 diabetes mellitus — A primary-care retrospective cohort study
  Andrew Kien Han Wee, Rehena Sultana
  BMC Primary Care.2023;[Epub]     CrossRef
• Risk factors for post-contrast acute kidney injury in patients sequentially administered iodine- and gadolinium-based contrast media on the same visit to the emergency department: a retrospective study
  Changshin Kang, Soo Hyun Han, Jung Soo Park, Dae Eun Choi
  Kidney Research and Clinical Practice.2023; 42(3): 358.     CrossRef
• Guideline for the diagnosis and treatment of diabetes mellitus in patients with transfusion-dependent thalassemia
  Mohammad E. Khamseh, Mojtaba Malek, Nahid Hashemi-madani, Fariba Ghassemi, Neda Rahimian, Amir Ziaee, Mohammad Reza Foroughi-Gilvaee, Pooya Faranoush, Negin Sadighnia, Ali Elahinia, Mohammad Reza Rezvany, Mohammad Faranoush
  Iranian Journal of Blood and Cancer.2023; 15(4): 293.     CrossRef
• Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis
  Ting-Wan Kao, Kuo-Hua Lee, Wing P. Chan, Kang-Chih Fan, Che-Wei Liu, Yu-Chen Huang
  European Radiology.2022; 32(5): 3045.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future
  Filipe Ferrari, Rafael S. Scheffel, Vítor M. Martins, Raul D. Santos, Ricardo Stein
  American Journal of Cardiovascular Drugs.2022; 22(4): 363.     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
  Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
  Eugene Han, Hye Soon Kim
  Diabetes & Metabolism Journal.2021; 45(6): 972.     CrossRef
• KRCP's past and future path
  Tae-Hyun Yoo
  Kidney Research and Clinical Practice.2020; 39(3): 233.     CrossRef
• Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
  Yao Hu, Min Lei, Guibao Ke, Xin Huang, Xuan Peng, Lihui Zhong, Ping Fu
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Pharmacotherapy for patients with diabetes mellitus
  Joon Ho Moon, Soo Lim
  Journal of the Korean Medical Association.2020; 63(12): 766.     CrossRef

The prevalence of obesity in Asia is of epidemic proportions, with an estimated 1 billion overweight/obese individuals in the region. The majority of patients with type 2 diabetes mellitus (T2DM) are overweight/obese, which increases the risk of cardiorenal outcomes in these patients; hence, sustained reductions in body weight and visceral adiposity are important management goals. However, most of the glucose-lowering therapies such as insulin, sulfonylureas, glinides, and thiazolidinediones induce weight gain, which makes the management of overweight/obese T2DM patients challenging. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are the only oral glucose-lowering agents that have been shown to reduce body weight and visceral adiposity. In addition, SGLT-2 inhibitors therapy reduces ectopic fat deposition and improves adipose tissue function and weight-related quality of life. In this article, we aim to consolidate the existing literature on the effects of SGLT-2 inhibitors in Asian patients with T2DM and to produce clinical recommendations on their use in overweight or obese patients with T2DM. Recommendations from international and regional guidelines, as well as published data from clinical trials in Asian populations and cardiovascular outcomes trials are reviewed. Based on the available data, SGLT-2 inhibitors represent an evidence-based therapeutic option for the management of overweight/obese patients with T2DM.

Citations

Citations to this article as recorded by  

• The interaction between non-coding RNAs and SGLT2: A review
  Joanna Jarosz-Popek, Ceren Eyileten, Gloria M. Gager, Anna Nowak, Piotr Szwed, Zofia Wicik, Jeff Palatini, Dirk von Lewinski, Harald Sourij, Jolanta M. Siller-Matula, Marek Postula
  International Journal of Cardiology.2024; 398: 131419.     CrossRef
• A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study
  Tae Seo Sohn, Kyung‐Ah Han, Yonghyun Kim, Byung‐Wan Lee, Suk Chon, In‐Kyung Jeong, Eun‐Gyoung Hong, Jang Won Son, JaeJin Na, Jae Min Cho, Seong In Cho, Wan Huh, Kun‐Ho Yoon
  Diabetes, Obesity and Metabolism.2024;[Epub]     CrossRef
• The effect of combining nutrient intake and physical activity levels on central obesity, sarcopenia, and sarcopenic obesity: a population-based cross-sectional study in South Korea
  Jong Eun Park, Seulgi Lee, Kirang Kim
  BMC Geriatrics.2023;[Epub]     CrossRef
• Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
  Minyoung Lee, Kyeongseob Jeong, Yu Rang Park, Yumie Rhee
  Metabolism.2023; 138: 155311.     CrossRef
• Efficacy and safety of janagliflozin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
  Leili Gao, Zhifeng Cheng, Benli Su, Xiuhai Su, Weihong Song, Yushan Guo, Lin Liao, Xiaowen Chen, Jiarui Li, Xingrong Tan, Fangjiang Xu, Shuguang Pang, Kun Wang, Jun Ye, Yuan Wang, Lili Chen, Jingfang Sun, Linong Ji
  Diabetes, Obesity and Metabolism.2023; 25(3): 785.     CrossRef
• Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
  Bains Jasleen, Gupta K Vishal, Malepati Sameera, Molla Fahad, O'Brien Brendan, Santander Deion, Sudhakar Pemminati
  Cureus.2023;[Epub]     CrossRef
• Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance
  Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won
  Diabetes & Metabolism Journal.2023; 47(1): 82.     CrossRef
• Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
  Linong Ji, Jie Liu, Zhi Jin Xu, Zhiqi Wei, Ruya Zhang, Seema Malkani, Nilo B. Cater, Robert Frederich
  Diabetes Therapy.2023; 14(2): 319.     CrossRef
• Research Progress of Dapagliflozin in Treatment of Acute Myocardial Infarction Complicated with Type 2 Diabetes Mellitus
  鸿 王
  Advances in Clinical Medicine.2023; 13(02): 1667.     CrossRef
• Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis
  Hye Jin Chun, Eun Ran Kim, Minyoung Lee, Da Hyun Choi, Soo Hyun Kim, Eugene Shin, Jin-Hong Kim, Jin Won Cho, Dai Hoon Han, Bong-Soo Cha, Yong-ho Lee
  Metabolism.2023; 145: 155612.     CrossRef
• Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
  Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, Tae Seo Sohn, In Kyung Jeong, Eun-Gyoung Hong, Jang Won Son, Jae Jin Nah, Hwa Rang Song, Seong In Cho, Seung-Ah Cho, Kun Ho Yoon
  Diabetes & Metabolism Journal.2023; 47(6): 796.     CrossRef
• Renoprotection with sodium‐glucose cotransporter‐2 inhibitors in children: Knowns and unknowns
  Buchun Jiang, Zhiwen Cheng, Fei Liu, Qiuyu Li, Haidong Fu, Jianhua Mao
  Nephrology.2022; 27(2): 126.     CrossRef
• Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
  Angelo Cignarelli, Valentina Annamaria Genchi, Giulia Le Grazie, Irene Caruso, Nicola Marrano, Giuseppina Biondi, Rossella D’Oria, Gian Pio Sorice, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
  Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi
  Journal of Diabetes Investigation.2022; 13(6): 986.     CrossRef
• Liraglutide Alleviates Diabetic Atherosclerosis through Regulating Calcification of Vascular Smooth Muscle Cells
  Li-Li Shi, Ming Hao, Zhou-Yun Jin, Gui-Fang Peng, Ying-Ying Tang, Hong-Yu Kuang, Yaoyao Bian
  Disease Markers.2022; 2022: 1.     CrossRef
• Relationship Between Four Non-Insulin-Based Indexes of Insulin Resistance and Serum Uric Acid in Patients with Type 2 Diabetes: A Cross-Sectional Study
  Rongfeng Han, Yang Zhang, Xia Jiang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1461.     CrossRef
• The dual role of empagliflozin: Cardio renal protection in T2DM patients
  Aimen Shafiq, Eman Mahboob, Muhammad Ammar Samad, Mohammad Hassam Ur Rehman, Zoaib Habib Tharwani
  Annals of Medicine & Surgery.2022;[Epub]     CrossRef
• Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy?
  Katarzyna Wołos-Kłosowicz, Wojciech Matuszewski, Joanna Rutkowska, Katarzyna Krankowska, Elżbieta Bandurska-Stankiewicz
  Journal of Clinical Medicine.2022; 11(20): 6183.     CrossRef
• Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development
  Ernest A. Adeghate, Huba Kalász, Saeeda Al Jaberi, Jennifer Adeghate, Kornelia Tekes
  Expert Opinion on Investigational Drugs.2021; 30(2): 85.     CrossRef
• Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
  Jianping Weng, Longyi Zeng, Yuwei Zhang, Shen Qu, Xueying Wang, Ping Li, Liujun Fu, Boqing Ma, Shandong Ye, Jiao Sun, Weiping Lu, Zhiwen Liu, Daoxiong Chen, Zhifeng Cheng, Haiyan Liu, Tao Zhang, Jianjun Zou
  Diabetes, Obesity and Metabolism.2021; 23(8): 1754.     CrossRef
• How do you treat obesity in the elderly pharmacologically?
  Claudio Daniel González, Guillermo Di Girolamo
  Expert Opinion on Pharmacotherapy.2021; 22(13): 1639.     CrossRef
• Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
  Ayako Nagayama, Kenji Ashida, Miki Watanabe, Kanoko Moritaka, Aya Sonezaki, Yoichiro Kitajima, Hirokazu Takahashi, Satoko Yoshinobu, Shimpei Iwata, Junichi Yasuda, Nao Hasuzawa, Shuichi Ozono, Seiichi Motomura, Masatoshi Nomura
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• New Pandemic: Obesity and Associated Nephropathy
  Isha Sharma, Yingjun Liao, Xiaoping Zheng, Yashpal S. Kanwar
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective
  Hayato Tanabe, Hiroaki Masuzaki, Michio Shimabukuro
  Diabetes Research and Clinical Practice.2021; 180: 109067.     CrossRef
• The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
  Mariana Tilinca, Robert Tiuca, Ioan Tilea, Andreea Varga
  Journal of Personalized Medicine.2021; 11(12): 1249.     CrossRef
• Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors
  Wayne H‐H Sheu
  Journal of Diabetes Investigation.2020; 11(5): 1115.     CrossRef

• SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients

  
  André J Scheen
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 2765.     CrossRef
• SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
  Yoshifumi Saisho
  Diseases.2020; 8(2): 14.     CrossRef
• Roles of Epicardial Adipose Tissue in the Pathogenesis of Coronary Atherosclerosis　― An Update on Recent Findings ―
  Kimie Tanaka, Daiju Fukuda, Masataka Sata
  Circulation Journal.2020; 85(1): 2.     CrossRef

Mitochondrial medicine is increasingly discussed as a promising therapeutic approach, given that mitochondrial defects are thought to contribute to many prevalent diseases and their complications. In individuals with diabetes mellitus (DM), defects in mitochondrial structure and function occur in many organs throughout the body, contributing both to the pathogenesis of DM and complications of DM. Diabetic cardiomyopathy (DbCM) is increasingly recognized as an underlying cause of increased heart failure in DM, and several mitochondrial mechanisms have been proposed to contribute to the development of DbCM. Well established mechanisms include myocardial energy depletion due to impaired adenosine triphosphate (ATP) synthesis and mitochondrial uncoupling, and increased mitochondrial oxidative stress. A variety of upstream mechanisms of impaired ATP regeneration and increased mitochondrial reactive oxygen species have been proposed, and recent studies now also suggest alterations in mitochondrial dynamics and autophagy, impaired mitochondrial Ca²⁺ uptake, decreased cardiac adiponectin action, increased O-GlcNAcylation, and impaired activity of sirtuins to contribute to mitochondrial defects in DbCM, among others. In the current review, we present and discuss the evidence that underlies both established and recently proposed mechanisms that are thought to contribute to mitochondrial dysfunction in DbCM.

Citations

Citations to this article as recorded by  

• SIRT1: a promising therapeutic target in type 2 diabetes mellitus
  Ainaz Mihanfar, Maryam Akbarzadeh, Saber Ghazizadeh Darband, Shirin Sadighparvar, Maryam Majidinia
  Archives of Physiology and Biochemistry.2024; 130(1): 13.     CrossRef
• Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy
  Feng Zhang, Jian jian Lin, Hao nan Tian, Jun Wang
  Experimental Physiology.2024; 109(2): 190.     CrossRef
• Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway
  Chennian Xu, Lin Xia, Dengyue Xu, Yang Liu, Ping Jin, Mengen Zhai, Yu Mao, Yiwei Wang, Anguo Wen, Jian Yang, Lifang Yang
  Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
• Ferroptosis: Mechanisms and role in diabetes mellitus and its complications
  Pan Liu, Zhengdong Zhang, Yichen Cai, Zhaoying Li, Qian Zhou, Qiu Chen
  Ageing Research Reviews.2024; 94: 102201.     CrossRef
• Salidroside Alleviates Myocardial Ischemia Reperfusion by Balancing Mitochondrial Homeostasis via Nrf2
  Tingxu Yan, Xu Li, Xin Wang, Bosai He, Ying Jia, Wei Xiao, Rong He
  Journal of Food Biochemistry.2024; 2024: 1.     CrossRef
• AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation
  Jiabing Zhan, Kunying Jin, Rong Xie, Jiahui Fan, Yuyan Tang, Chen Chen, Huaping Li, Dao Wen Wang
  Circulation.2024; 149(14): 1102.     CrossRef
• Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
  Ren Jie Phang, Rebecca H Ritchie, Derek J Hausenloy, Jarmon G Lees, Shiang Y Lim
  Cardiovascular Research.2023; 119(3): 668.     CrossRef
• Mitochondrial miRNA as epigenomic signatures: Visualizing aging-associated heart diseases through a new lens
  Jasvinder Singh Bhatti, Naina Khullar, Rajesh Vijayvergiya, Umashanker Navik, Gurjit Kaur Bhatti, P. Hemachandra Reddy
  Ageing Research Reviews.2023; 86: 101882.     CrossRef
• Eucommiae Folium and Active Compounds Protect Against Mitochondrial Dysfunction-Calcium Overload in Epileptic Hippocampal Neurons Through the Hypertrophic Cardiomyopathy Pathway
  Shuai-nan Zhang, Hong-mei Li, Qi Liu, Xu-zhao Li, Wu-de Yang, Ying Zhou
  Neurochemical Research.2023; 48(9): 2674.     CrossRef
• Speckle-tracking echocardiography provides sensitive measurements of subtle early alterations associated with cardiac dysfunction in T2DM rats
  Yanchao Qi, Zhiyan Chen, Bingyan Guo, Zhe Liu, Lijie Wang, Suyun Liu, Lixiang Xue, Meifang Ma, Yajuan Yin, Yongjun Li, Gang Liu
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments
  Fumin Zhi, Qian Zhang, Li Liu, Xing Chang, Hongtao Xu
  Cell Stress and Chaperones.2023; 28(6): 641.     CrossRef
• Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury
  Weixing Wen, Haoxiao Zheng, Weiwen Li, Guolin Huang, Peng Chen, Xiaolin Zhu, Yue Cao, Jiahuan Li, Xiaohui Huang, Yuli Huang
  Metabolism.2023; 147: 155662.     CrossRef
• Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference
  Panpan Liu, Zhuli Yang, Youjun Wang, Aomin Sun
  International Journal of Molecular Sciences.2023; 24(17): 13188.     CrossRef
• Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
  Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, Marco Fiorillo, Francesco Moccia, Giuseppe Viglietto, Tommaso Angelone, Nicola Amodio
  Journal of Translational Medicine.2023;[Epub]     CrossRef
• Triarylphosphonium compounds as effective vectors for mitochondria-targeted delivery systems: decoration strategies and prospects for clinical application
  T. N. Pashirova, A. V. Nemtarev, E. B. Souto, V. F. Mironov
  Russian Chemical Reviews.2023; 92(10): RCR5095.     CrossRef
• Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats
  Sarah D’Haese, Maxim Verboven, Lize Evens, Dorien Deluyker, Ivo Lambrichts, BO Eijnde, Dominique Hansen, Virginie Bito
  Nutrients.2023; 15(18): 3950.     CrossRef
• Alpha-lipoic acid enhances ischemic postconditioning-mediated improvement of myocardial infarction and apoptosis in diabetic rats with ischemia/reperfusion injury
  Sanaz Gholami, Reza Badalzadeh, Alireza Alihemmati
  Canadian Journal of Physiology and Pharmacology.2023; 101(12): 682.     CrossRef
• Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
  Qutuba G Karwi, Kim L Ho, Simran Pherwani, Ezra B Ketema, Qiuyu Sun, Gary D Lopaschuk
  Cardiovascular Research.2022; 118(3): 686.     CrossRef
• Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy
  Carolina Jaquenod De Giusti, Julieta Palomeque, Alicia Mattiazzi
  Pflügers Archiv - European Journal of Physiology.2022; 474(1): 33.     CrossRef
• Double-edge sword roles of iron in driving energy production versus instigating ferroptosis
  Shuping Zhang, Wei Xin, Gregory J. Anderson, Ruibin Li, Ling Gao, Shuguang Chen, Jiajun Zhao, Sijin Liu
  Cell Death & Disease.2022;[Epub]     CrossRef
• Differential remodelling of mitochondrial subpopulations and mitochondrial dysfunction are a feature of early stage diabetes
  Bodour S. Rajab, Sarah Kassab, Connor D. Stonall, Hussam Daghistani, Stephen Gibbons, Mamas Mamas, David Smith, Aleksandr Mironov, Zainab AlBalawi, Yin Hua Zhang, Florence Baudoin, Min Zi, Sukhpal Prehar, Elizabeth J. Cartwright, Ashraf Kitmitto
  Scientific Reports.2022;[Epub]     CrossRef
• GlyNAC (Glycine and N-Acetylcysteine) Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study
  Rajagopal V. Sekhar
  Antioxidants.2022; 11(1): 154.     CrossRef
• Glucose-derived posttranslational modification in cardiovascular disease
  Michael Lehrke, Julia Moellmann, Florian Kahles, Nikolaus Marx
  Molecular Aspects of Medicine.2022; 86: 101084.     CrossRef
• Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts
  Anastasia V. Poznyak, Tatiana V. Kirichenko, Evgeny E. Borisov, Nikolay K. Shakhpazyan, Andrey G. Kartuesov, Alexander N. Orekhov
  International Journal of Molecular Sciences.2022; 23(6): 2951.     CrossRef
• Editorial: Management of Diabetes and its Complications: A Focus on Endothelial Dysfunction
  Shanhu Qiu, Jianhua Ma, Tongzhi Wu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Alternative autophagy: mechanisms and roles in different diseases
  Hong Feng, Nian Wang, Nan Zhang, Hai-han Liao
  Cell Communication and Signaling.2022;[Epub]     CrossRef
• Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors
  Siarhei A. Dabravolski, Alexander D. Zhuravlev, Andrey G. Kartuesov, Evgeny E. Borisov, Vasily N. Sukhorukov, Alexander N. Orekhov
  International Journal of Molecular Sciences.2022; 23(10): 5371.     CrossRef
• Animal Models of Dysregulated Cardiac Metabolism
  Heiko Bugger, Nikole J. Byrne, E. Dale Abel
  Circulation Research.2022; 130(12): 1965.     CrossRef
• Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease
  Jianguo Lin, Jinlong Duan, Qingqing Wang, Siyu Xu, Simin Zhou, Kuiwu Yao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids
  Ronghui Han, Hemeng Huang, Weiyi Xia, Jingjin Liu, Hui Luo, Jing Tang, Zhengyuan Xia
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
  Misganaw Asmamaw Mengstie, Endeshaw Chekol Abebe, Awgichew Behaile Teklemariam, Anemut Tilahun Mulu, Assefa Agegnehu Teshome, Edgeit Abebe Zewde, Zelalem Tilahun Muche, Muluken Teshome Azezew
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effect of Chronic Treatment with Uridine on Cardiac Mitochondrial Dysfunction in the C57BL/6 Mouse Model of High-Fat Diet–Streptozotocin-Induced Diabetes
  Natalia V. Belosludtseva, Vlada S. Starinets, Irina B. Mikheeva, Maxim N. Belosludtsev, Mikhail V. Dubinin, Galina D. Mironova, Konstantin N. Belosludtsev
  International Journal of Molecular Sciences.2022; 23(18): 10633.     CrossRef
• FGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
  Leigang Jin, Leiluo Geng, Lei Ying, Lingling Shu, Kevin Ye, Ranyao Yang, Yan Liu, Yao Wang, Yin Cai, Xue Jiang, Qin Wang, Xingqun Yan, Boya Liao, Jie Liu, Fuyu Duan, Gary Sweeney, Connie Wai Hong Woo, Yu Wang, Zhengyuan Xia, Qizhou Lian, Aimin Xu
  Circulation.2022; 146(20): 1537.     CrossRef
• Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy
  Jing Bai, Chuanbin Liu, Pingjun Zhu, Yang Li
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets
  Khalil Saadeh, Ibrahim Talal Fazmin
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling
  Fan Ying, Hao Liu, Eva Hoi Ching Tang, Ishan Lakhani, Ningning Liu, Zhengyuan Xia, Shiming Liu
  Biochemical and Biophysical Research Communications.2021; 548: 196.     CrossRef
• Study of long non-coding RNA and mitochondrial dysfunction in diabetic rats
  Haytham K. Sultan, Wael M. El-Ayat, Azza H. AbouGhalia, Noha N. Lasheen, Amr S. Moustafa
  Tissue and Cell.2021; 71: 101516.     CrossRef
• A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates
  Xiu Wang, Shi Jin, Weina Hu, Gaetano Santulli
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef
• Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy
  Uzair Ahmed, Usman Ali Ashfaq, Muhammad Qasim, Imtiaz Ahmad, Hafiz Usman Ahmad, Muhammad Tariq, Muhammad Shareef Masoud, Saba Khaliq, Muhammad Younas Khan Barozai
  PLOS ONE.2021; 16(4): e0250773.     CrossRef
• MicroRNAs Regulating Mitochondrial Function in Cardiac Diseases
  Guang-Qiong Zhang, Sheng-Quan Wang, Yan Chen, Ling-Yun Fu, Yi-Ni Xu, Ling Li, Ling Tao, Xiang-Chun Shen
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy in rats through autophagic pathway
  Salma M. Eraky, Nehal M. Ramadan
  The Journal of Nutritional Biochemistry.2021; 97: 108798.     CrossRef
• Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
  Mao Liu, Jiao Ai, Zhuang Shuai, Kai Tang, Zongyu Li, Yin Huang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
  Izabela Tuleta, Nikolaos G. Frangogiannis
  Advanced Drug Delivery Reviews.2021; 176: 113904.     CrossRef
• Effect of the MPT Pore Inhibitor Alisporivir on the Development of Mitochondrial Dysfunction in the Heart Tissue of Diabetic Mice
  Natalia V. Belosludtseva, Vlada S. Starinets, Irina B. Mikheeva, Dmitriy A. Serov, Maxim E. Astashev, Maxim N. Belosludtsev, Mikhail V. Dubinin, Konstantin N. Belosludtsev
  Biology.2021; 10(9): 839.     CrossRef
• Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
  Alex M. Parker, Mitchel Tate, Darnel Prakoso, Minh Deo, Andrew M. Willis, David M. Nash, Daniel G. Donner, Simon Crawford, Helen Kiriazis, Cesare Granata, Melinda T. Coughlan, Miles J. De Blasio, Rebecca H. Ritchie
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Radiation‑induced dysfunction of energy metabolism in the heart results in the fibrosis of cardiac tissues
  Peng Xu, Yali Yi, Yijing Luo, Zhicheng Liu, Yilin Xu, Jing Cai, Zhimin Zeng, Anwen Liu
  Molecular Medicine Reports.2021;[Epub]     CrossRef
• Heart Failure and Diabetes: Perspective of a Dangerous Association
  Liliana E. Favaloro, Roxana D. Ratto, Carla Musso
  Current Hypertension Reviews.2021; 17(2): 85.     CrossRef
• CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response
  Bernd Niemann, Ling Li, Dorothee Siegler, Benedikt H. Siegler, Fabienne Knapp, Jakob Hanna, Muhammad Aslam, Michael Kracht, Rainer Schulz, Susanne Rohrbach
  Cells.2020; 9(5): 1229.     CrossRef
• The Hippo Pathway Orchestrates Mitochondrial Quality Control: A Novel Focus on Cardiovascular Diseases
  Ying Tan, Cai Lei, Huifang Tang, Xiao Zhu, Guanghui Yi
  DNA and Cell Biology.2020; 39(9): 1494.     CrossRef
• Adeno-Associated Viral Transfer of Glyoxalase-1 Blunts Carbonyl and Oxidative Stresses in Hearts of Type 1 Diabetic Rats
  Fadhel A. Alomar, Abdullah Al-Rubaish, Fahad Al-Muhanna, Amein K. Al-Ali, JoEllyn McMillan, Jaipaul Singh, Keshore R. Bidasee
  Antioxidants.2020; 9(7): 592.     CrossRef
• Loss of function of transcription factor EB remodels lipid metabolism and cell death pathways in the cardiomyocyte
  Purvi C. Trivedi, Jordan J. Bartlett, Angella Mercer, Logan Slade, Marc Surette, Andrea Ballabio, Stephane Flibotte, Bahira Hussein, Brian Rodrigues, Petra C. Kienesberger, Thomas Pulinilkunnil
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(10): 165832.     CrossRef
• Rescue of myocardial energetic dysfunction in diabetes through the correction of mitochondrial hyperacetylation by honokiol
  Matthew Kerr, Jack J. Miller, Dharendra Thapa, Sophie Stiewe, Kerstin N. Timm, Claudia N. Montes Aparicio, Iain Scott, Damian J. Tyler, Lisa C. Heather
  JCI Insight.2020;[Epub]     CrossRef
• Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
  Konstantin N. Belosludtsev, Natalia V. Belosludtseva, Mikhail V. Dubinin
  International Journal of Molecular Sciences.2020; 21(18): 6559.     CrossRef
• Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes
  Rocchina Vilella, Gianluca Sgarbi, Valeria Naponelli, Monia Savi, Leonardo Bocchi, Francesca Liuzzi, Riccardo Righetti, Federico Quaini, Caterina Frati, Saverio Bettuzzi, Giancarlo Solaini, Donatella Stilli, Federica Rizzi, Alessandra Baracca
  Nutrients.2020; 12(10): 2949.     CrossRef
• Diabetic cardiomyopathy: definition, diagnosis criteria, treatment directions and prevention of heart failure
  N. A. Koziolova, P. G. Karavaev, A. S. Veklich
  South Russian Journal of Therapeutic Practice.2020; 1(2): 93.     CrossRef
• Adiponectin protects HL-1 cardiomyocytes against rotenone-induced cytotoxicity through AMPK activation
  Biao Li, Baojian Zhang, Na Liu, Keke Wu, Yingxu Ma, Wanyun Zuo, Zuodong Ning, Yaozhong Liu, Chao Sun, Yichao Xiao, Tao Tu, Qiming Liu
  Toxicology Letters.2020; 335: 82.     CrossRef
• Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells
  Nicholas Esch, Seokwon Jo, Mackenzie Moore, Emilyn U. Alejandro, Yingke Xu
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
  Ehtasham Ahmad, Jack Sargeant, Francesco Zaccardi, Kamlesh Khunti, David Webb, Melanie Davies
  Pharmaceuticals.2020; 13(12): 427.     CrossRef

Obesity, diabetes, and cardiovascular diseases are increasing rapidly worldwide and it is therefore important to know the effect of exercise and medications for diabetes and obesity on adult stem cells. Adult stem cells play a major role in remodeling and tissue regeneration. In this review we will focus mainly on two adult stem/progenitor cells such as endothelial progenitor cells and mesenchymal stromal cells in relation to aerobic exercise and diabetes medications, both of which can alter the course of regeneration and tissue remodelling. These two adult precursor and stem cells are easily obtained from peripheral blood or adipose tissue depots, as the case may be and are precursors to endothelium and mesenchymal tissue (fat, bone, muscle, and cartilage). They both are key players in maintenance of cardiovascular and metabolic homeostasis and can act also as useful biomarkers.

Citations

Citations to this article as recorded by  

• Novel Therapeutics in Nonalcoholic Fatty Liver Disease: A Focus on Adult Stem Cells
  Seshagiri Rao Nandula, Eric S. Nylen, Sabyasachi Sen
  Metabolic Syndrome and Related Disorders.2023; 21(2): 71.     CrossRef
• Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
  Antonio Alma, Guya Diletta Marconi, Elena Rossi, Cristina Magnoni, Alessia Paganelli
  Life.2023; 13(3): 717.     CrossRef
• Stem Cells in Tendon Regeneration and Factors governing Tenogenesis
  Lingli Ding, BingYu Zhou, Yonghui Hou, Liangliang Xu
  Current Stem Cell Research & Therapy.2022; 17(6): 503.     CrossRef
• Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
  Seshagiri Rao Nandula, Nabanita Kundu, Hassan B. Awal, Beda Brichacek, Mona Fakhri, Nikhila Aimalla, Adrian Elzarki, Richard L. Amdur, Sabyasachi Sen
  Cardiovascular Diabetology.2021;[Epub]     CrossRef
• Tailored generation of insulin producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissue
  Watchareewan Rodprasert, Sirirat Nantavisai, Koranis Pathanachai, Prasit Pavasant, Thanaphum Osathanon, Chenphop Sawangmake
  Scientific Reports.2021;[Epub]     CrossRef

Chronic energy surplus increases body fat, leading to obesity. Since obesity is closely associated with most metabolic complications, pathophysiological roles of adipose tissue in obesity have been intensively studied. White adipose tissue is largely divided into subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). These two white adipose tissues are similar in their appearance and lipid storage functions. Nonetheless, emerging evidence has suggested that SAT and VAT have different characteristics and functional roles in metabolic regulation. It is likely that there are intrinsic differences between VAT and SAT. In diet-induced obese animal models, it has been reported that adipogenic progenitors in VAT rapidly proliferate and differentiate into adipocytes. In obesity, VAT exhibits elevated inflammatory responses, which are less prevalent in SAT. On the other hand, SAT has metabolically beneficial effects. In this review, we introduce recent studies that focus on cellular and molecular components modulating adipogenesis and immune responses in SAT and VAT. Given that these two fat depots show different functions and characteristics depending on the nutritional status, it is feasible to postulate that SAT and VAT have different developmental origins with distinct adipogenic progenitors, which would be a key determining factor for the response and accommodation to metabolic input for energy homeostasis.

Citations

Citations to this article as recorded by  

• Lipodystrophy as a target to delay premature aging
  Daniela G. Costa, Marisa Ferreira-Marques, Cláudia Cavadas
  Trends in Endocrinology & Metabolism.2024; 35(2): 97.     CrossRef
• Subcutaneous fat predicts bone metastasis in breast cancer: A novel multimodality-based deep learning model
  Shidi Miao, Haobo Jia, Wenjuan Huang, Ke Cheng, Wenjin Zhou, Ruitao Wang
  Cancer Biomarkers.2024; 39(3): 171.     CrossRef
• Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke
  Kayo Wakisaka, Ryu Matsuo, Fumi Irie, Yoshinobu Wakisaka, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Masaki Mogi
  PLOS ONE.2024; 19(1): e0296833.     CrossRef
• NOTCH1 as a Negative Regulator of Avian Adipocyte Differentiation: Implications for Fat Deposition
  Zheng Wang, Yue Su, Mingyu Zhao, Zhenhua Ma, Jianhui Li, Zhuocheng Hou, Huifeng Li
  Animals.2024; 14(4): 585.     CrossRef
• Green tea beneficial effects involve changes in the profile of immune cells in the adipose tissue of obese mice
  Kaue Tognolli, Victoria Silva, Celso Pereira Batista Sousa-Filho, Claudia Andrea Lima Cardoso, Renata Gorjão, Rosemari Otton
  European Journal of Nutrition.2023; 62(1): 321.     CrossRef
• Mechanic Insight into the Distinct and Common Roles of Ovariectomy Versus Adrenalectomy on Adipose Tissue Remodeling in Female Mice
  Weihao Chen, Fengyan Meng, Xianyin Zeng, Xiaohan Cao, Guixian Bu, Xiaogang Du, Guozhi Yu, Fanli Kong, Yunkun Li, Tian Gan, Xingfa Han
  International Journal of Molecular Sciences.2023; 24(3): 2308.     CrossRef
• High-fat diet consumption by male rat offspring of obese mothers exacerbates adipose tissue hypertrophy and metabolic alterations in adult life
  Guadalupe L. Rodríguez-González, Sergio De Los Santos, Dayana Méndez-Sánchez, Luis A. Reyes-Castro, Carlos A. Ibáñez, Patricia Canto, Elena Zambrano
  British Journal of Nutrition.2023; 130(5): 783.     CrossRef
• Obesity and the risk of cardiometabolic diseases
  Pedro L. Valenzuela, Pedro Carrera-Bastos, Adrián Castillo-García, Daniel E. Lieberman, Alejandro Santos-Lozano, Alejandro Lucia
  Nature Reviews Cardiology.2023; 20(7): 475.     CrossRef
• Abdominal fat and muscle distributions in different stages of colorectal cancer
  Jun Han, Xinyang Liu, Min Tang, Fan Yang, Zuoyou Ding, Guohao Wu
  BMC Cancer.2023;[Epub]     CrossRef
• Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
  Sofía Elena Tesolato, Daniel González-Gamo, Ana Barabash, Paula Claver, Sofía Cristina de la Serna, Inmaculada Domínguez-Serrano, Jana Dziakova, Carmen de Juan, Antonio José Torres, Pilar Iniesta
  Cancers.2023; 15(13): 3324.     CrossRef
• Lower subcutaneous fat index predicts bone metastasis in breast cancer
  Wen Wang, Wen-Juan Huang, Ping-Ping Liu, Shuang Fu, Meng-Lin Zhang, Xin Zhang, Rui-Tao Wang, Yuan-Xi Huang
  Cancer Biomarkers.2023; 38(1): 121.     CrossRef
• RabGAP AS160/TBC1D4 deficiency increases long-chain fatty acid transport but has little additional effect on obesity and metabolic syndrome in ADMSCs-derived adipocytes of morbidly obese women
  Agnieszka Mikłosz, Bartłomiej Łukaszuk, Elżbieta Supruniuk, Kamil Grubczak, Magdalena Kusaczuk, Adrian Chabowski
  Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
• White adipose tissue: Distribution, molecular insights of impaired expandability, and its implication in fatty liver disease
  Griselda Rabadán-Chávez, Rocío I. Díaz de la Garza, Daniel A. Jacobo-Velázquez
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2023; 1869(8): 166853.     CrossRef
• Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity
  A. Basolo, A. M. Poma, R. Giannini, G. Ceccarini, C. Pelosini, P. Fierabracci, M. U. Castany, S. Bechi Genzano, C. E. Ambrosini, G. Materazzi, L. Chiovato, F. Basolo, F. Santini, L. Torregrossa
  Journal of Endocrinological Investigation.2022; 45(2): 413.     CrossRef
• Predictors of non-alcoholic fatty liver disease in children
  Menglong Li, Wen Shu, Jiawulan Zunong, Nubiya Amaerjiang, Huidi Xiao, Dan Li, Sten H. Vermund, Yifei Hu
  Pediatric Research.2022; 92(1): 322.     CrossRef
• Distinct properties of adipose stem cell subpopulations determine fat depot-specific characteristics
  Hahn Nahmgoong, Yong Geun Jeon, Eun Seo Park, Yoon Ha Choi, Sang Mun Han, Jeu Park, Yul Ji, Jee Hyung Sohn, Ji Seul Han, Ye Young Kim, Injae Hwang, Yun Kyung Lee, Jin Young Huh, Sung Sik Choe, Tae Jung Oh, Sung Hee Choi, Jong Kyoung Kim, Jae Bum Kim
  Cell Metabolism.2022; 34(3): 458.     CrossRef
• WT1 in Adipose Tissue: From Development to Adult Physiology
  Karin M. Kirschner, Holger Scholz
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Shall We Begin the Voyage of Adipose Tissue Exploration?
  Yong Geun Jeon
  Molecules and Cells.2022; 45(6): 362.     CrossRef
• Mammalian adipogenesis regulator (Areg) cells use retinoic acid signalling to be non‐ and anti‐adipogenic in age‐dependent manner
  Magda Zachara, Pernille Y Rainer, Horia Hashimi, Julie M Russeil, Daniel Alpern, Radiana Ferrero, Maria Litovchenko, Bart Deplancke
  The EMBO Journal.2022;[Epub]     CrossRef
• The fates of different types of adipose tissue after transplantation in mice
  Shenglu Jiang, Jiayan Lin, Qian Zhang, Yunjun Liao, Feng Lu, Junrong Cai
  The FASEB Journal.2022;[Epub]     CrossRef
• Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
  Jun Han, Zuoyou Ding, Qiulin Zhuang, Lei Shen, Fan Yang, Szechun Sah, Guohao Wu
  Nutrition & Metabolism.2022;[Epub]     CrossRef
• Adipose Stromal/Stem Cell-Derived Extracellular Vesicles: Potential Next-Generation Anti-Obesity Agents
  Mariachiara Zuccarini, Patricia Giuliani, Valentina Di Liberto, Monica Frinchi, Francesco Caciagli, Vanni Caruso, Renata Ciccarelli, Giuseppa Mudò, Patrizia Di Iorio
  International Journal of Molecular Sciences.2022; 23(3): 1543.     CrossRef
• Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project
  Enric Sánchez, Marta Sánchez, Carolina López-Cano, Marcelino Bermúdez-López, José Manuel Valdivielso, Cristina Farràs-Sallés, Reinald Pamplona, Gerard Torres, Dídac Mauricio, Eva Castro, Elvira Fernández, Albert Lecube
  Nutrients.2022; 15(1): 203.     CrossRef
• Insights behind the Relationship between Colorectal Cancer and Obesity: Is Visceral Adipose Tissue the Missing Link?
  Alice Chaplin, Ramon Maria Rodriguez, Juan José Segura-Sampedro, Aina Ochogavía-Seguí, Dora Romaguera, Gwendolyn Barceló-Coblijn
  International Journal of Molecular Sciences.2022; 23(21): 13128.     CrossRef
• Potential effects of nutrition-based weight loss therapies in reversing obesity-related breast cancer epigenetic marks
  Paula M. Lorenzo, Ana B. Crujeiras
  Food & Function.2021; 12(4): 1402.     CrossRef
• Metabolomic Profiles in Adipocytes Differentiated from Adipose-Derived Stem Cells Following Exercise Training or High-Fat Diet
  Seita Osawa, Hisashi Kato, Yuki Maeda, Hisashi Takakura, Junetsu Ogasawara, Tetsuya Izawa
  International Journal of Molecular Sciences.2021; 22(2): 966.     CrossRef
• Adipocytes Are the Control Tower That Manages Adipose Tissue Immunity by Regulating Lipid Metabolism
  Jeu Park, Jee Hyung Sohn, Sang Mun Han, Yoon Jeong Park, Jin Young Huh, Sung Sik Choe, Jae Bum Kim
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Ceramides and Sphingosino-1-Phosphate in Obesity
  Ilona Juchnicka, Mariusz Kuźmicki, Jacek Szamatowicz
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment
  Christine Bourgeois, Jennifer Gorwood, Anaelle Olivo, Laura Le Pelletier, Jacqueline Capeau, Olivier Lambotte, Véronique Béréziat, Claire Lagathu
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Subcutaneous, but not visceral, adipose tissue as a marker for prognosis in gastric cancer patients with cachexia
  Jun Han, Min Tang, Chaocheng Lu, Lei Shen, Jiaqi She, Guohao Wu
  Clinical Nutrition.2021; 40(9): 5156.     CrossRef
• miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients
  Diya Sun, Zuoyou Ding, Lei Shen, Fan Yang, Jun Han, Guohao Wu
  Lipids in Health and Disease.2021;[Epub]     CrossRef
• Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands
  Mariachiara Zuccarini, Catia Lambertucci, Marzia Carluccio, Patricia Giuliani, Maurizio Ronci, Andrea Spinaci, Rosaria Volpini, Renata Ciccarelli, Patrizia Di Iorio
  Cells.2021; 10(12): 3560.     CrossRef
• Obesity: The Crossroads of Opinion, Knowledge, and Opportunity
  L. A. Ruyatkina, D. S. Ruyatkin
  Meditsinskiy sovet = Medical Council.2020; (7): 108.     CrossRef
• Sex Differences in Long-term Metabolic Effects of Maternal Resveratrol Intake in Adult Rat Offspring
  Purificación Ros, Francisca Díaz, Alejandra Freire-Regatillo, Pilar Argente-Arizón, Vicente Barrios, Jesús Argente, Julie A Chowen
  Endocrinology.2020;[Epub]     CrossRef
• Adipose stem cells in obesity: challenges and opportunities
  Sunhye Shin, Asma S. El-Sabbagh, Brandon E. Lukas, Skylar J. Tanneberger, Yuwei Jiang
  Bioscience Reports.2020;[Epub]     CrossRef
• Clinical and pathogenetic rationale for the prevention and treatment of obesity
  O.M. Korzh
  Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini.2020; 2020(2): 146.     CrossRef
• OBESITY: CLINICAL AND PATHOGENETIC JUSTIFICATION OF PREVENTION AND TREATMENT
  O. M. Korzh
  International Medical Journal.2020; (2): 5.     CrossRef
• The Effect and Mechanism of Subcutaneous and Visceral Adipose Tissue Loss on Gastric Cancer Patients With Cachexia
  Jun Han, Min Tang, Guyue Zhang, Chaocheng Lu, Jiaqi She, Guohao Wu
  SSRN Electronic Journal .2020;[Epub]     CrossRef

Cancer incidence appears to be increased in both type 1 and type 2 diabetes mellitus (DM). DM represents a risk factor for cancer, particularly hepatocellular, hepatobiliary, pancreas, breast, ovarian, endometrial, and gastrointestinal cancers. In addition, there is evidence showing that DM is associated with increased cancer mortality. Common risk factors such as age, obesity, physical inactivity and smoking may contribute to increased cancer risk in patients with DM. Although the mechanistic process that may link diabetes to cancer is not completely understood yet, biological mechanisms linking DM and cancer are hyperglycemia, hyperinsulinemia, increased bioactivity of insulin-like growth factor 1, oxidative stress, dysregulations of sex hormones, and chronic inflammation. However, cancer screening rate is significantly lower in people with DM than that in people without diabetes. Evidence from previous studies suggests that some medications used to treat DM are associated with either increased or reduced risk of cancer. However, there is no strong evidence supporting the association between the use of anti-hyperglycemic medication and specific cancer. In conclusion, all patients with DM should be undergo recommended age- and sex appropriate cancer screenings to promote primary prevention and early detection. Furthermore, cancer should be screened in routine diabetes assessment.

Citations

Citations to this article as recorded by  

• 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024
  Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Laya Ekhlaspour, Talya K. Fleming, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Nicola Napoli
  Diabetes Care.2024; 47(Supplement): S52.     CrossRef
• Editorial: The relationship between diabetes and cancers and its underlying mechanisms, volume II
  Qiang Huo, Shuo Wang, Ying Hou, Reginald M. Gorczynski, Yining Shen, Bin Wang, Hanyi Ge, Tao Li
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control study
  Kwangwoo Nam, Su Youn Nam, Jun Chul Park, Young Sin Cho, Hyuk Soon Choi, Kyoungwon Jung, Seon-Young Park, Joon Hyun Cho, Hyonho Chun
  Digestive and Liver Disease.2024;[Epub]     CrossRef
• Exploring Perspectives on Cancer Screening in People Aged 30-70: A Comparative Study of Those With and Without Type 2 Diabetes
  Yunus GÜR, Egemen TURAL, Akın DAYAN
  Konuralp Tıp Dergisi.2024; 16(1): 26.     CrossRef
• Prognostic significance of glucose‐lipid metabolic index in pancreatic cancer patients with diabetes mellitus
  Hailiang Wang, Shiye Ruan, Zelong Wu, Qian Yan, Yubin Chen, Jinwei Cui, Zhongyan Zhang, Shanzhou Huang, Baohua Hou, Chuanzhao Zhang
  Cancer Medicine.2024;[Epub]     CrossRef
• Preoperative glucose-to-lymphocyte ratio predicts survival in cancer
  Le Liu, Bei-bei Zhang, Yuan-zhou Li, Wen-juan Huang, Ye Niu, Qing-chun Jia, Wen Wang, Jia-rui Yuan, Shi-di Miao, Rui-tao Wang, Guang-yu Wang
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Higher Prevalence of Cancer in Patients with Diabetic Foot Syndrome
  Chiara Goretti, Alessandro Prete, Alex Brocchi, Elisabetta Iacopi, Letizia Pieruzzi, Alberto Piaggesi
  Journal of Clinical Medicine.2024; 13(5): 1448.     CrossRef
• Patterns and Trends in Mortality Associated With and Due to Diabetes Mellitus in a Transitioning Region With 3.17 Million People: Observational Study
  Xiaopan Li, Ru Liu, Yichen Chen, Yan Han, Qizhe Wang, Yaxin Xu, Jing Zhou, Sunfang Jiang
  JMIR Public Health and Surveillance.2023; 9: e43687.     CrossRef
• Diabetes and cancer: Optimising glycaemic control
  Nalinie Joharatnam‐Hogan, Daniel L. Morganstein
  Journal of Human Nutrition and Dietetics.2023; 36(2): 504.     CrossRef
• Need for improving immunization status and preventive care in diabetes mellitus patients
  Teresa Gisinger, Alexandra Kautzky-Willer, Michael Leutner
  Wiener klinische Wochenschrift.2023; 135(13-14): 336.     CrossRef
• Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study
  Dong-Hoe Koo, Kyungdo Han, Cheol-Young Park
  Diabetes Research and Clinical Practice.2023; 195: 110208.     CrossRef
• Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
  Zhihong Yue, Lin Pei, Guangyan Meng, Aimin Zhang, Meng Li, Mei Jia, Hui Wang, Linlin Cao
  Metabolites.2023; 13(1): 90.     CrossRef
• Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis
  Margaret A. Heller, Sarah C. Nyirjesy, Robert Balsiger, Nicholas Talbot, Kyle K. VanKoevering, Catherine T. Haring, Matthew O. Old, Stephen Y. Kang, Nolan B. Seim
  Oral Oncology.2023; 137: 106300.     CrossRef
• Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
  Alessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, Francesco Perri, Marco Cascella, Francesco Sabbatino, Maurizio Capuozzo, Vincenza Granata, Silvia Zappavigna, Angela Lombardi, Marianna Scrima, Nadia Petrillo, Monica Ianniello, Marika Casillo,
  Frontiers in Medicine.2023;[Epub]     CrossRef
• The relationship between the CUN-BAE body fatness index and incident diabetes: a longitudinal retrospective study
  Qing Peng, Zihao Feng, Zhuojian Cai, Dixing Liu, Jiana Zhong, Hejia Zhao, Xiuwei Zhang, Weikun Chen
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Association of four lipid-derived indicators with the risk of developing type 2 diabetes: a Chinese population-based cohort study
  Linfeng He, Wenbin Zheng, Zeyu Li, Wen Kong, Tianshu Zeng
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Screening for Coronary Artery Disease in Cancer Survivors
  Ragani Velusamy, Mark Nolan, Andrew Murphy, Paaladinesh Thavendiranathan, Thomas H. Marwick
  JACC: CardioOncology.2023; 5(1): 22.     CrossRef
• Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and in vitro validation
  Yejun Tan, Jin Kang, Hongli Li, Aifang Zhong, Yaqiong Liu, Zheyu Zhang, Roujie Huang, Xin Cheng, Weijun Peng
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Increased Breast and Colorectal Cancer Risk in Type 2 Diabetes: Awareness Among Adults With and Without Diabetes and Information Provision on Diabetes Websites
  Laura Ashley, Kathryn A Robb, Daryl B O’Connor, Rebecca Platt, Mollie Price, Olivia Robinson, Elizabeth Travis, Lorraine Lipscombe, Ramzi Ajjan, Rebecca Birch
  Annals of Behavioral Medicine.2023; 57(5): 386.     CrossRef
• Primary peritoneal serous psammocarcinoma, rare variant: A case report
  Srujan Kancharla, Anne Alaniz, Pulin Kothari, Stacy Norton
  Gynecologic Oncology Reports.2023; 47: 101176.     CrossRef
• Association between the Finnish Diabetes Risk Score and cancer in middle-aged and older adults: Involvement of inflammation
  Yu Peng, Peng Wang, Jianxiao Gong, Fubin Liu, Yating Qiao, Changyu Si, Xixuan Wang, Huijun Zhou, Fangfang Song
  Metabolism.2023; 144: 155586.     CrossRef
• Interlinking of diabetes mellitus and cancer: An overview
  Iftikhar Ahmad, Mohd Suhail, Ausaf Ahmad, Mahmoud Alhosin, Shams Tabrez
  Cell Biochemistry and Function.2023; 41(5): 506.     CrossRef
• High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist
  Bingwei Ma, Xingchun Wang, Hui Ren, Yingying Li, Haijiao Zhang, Muqing Yang, Jiyu Li
  BMC Cancer.2023;[Epub]     CrossRef
• Diabetes mellitus and the female reproductive system tumors
  K. I. Sharafutdinova, V. S. Shlyapina, A. I. Baeva, A. A. Timurshin, I. E. Sabanaeva, A. G. Nakieva, M. F. Kalashnikova, M. N. Khabibov
  Problems of Endocrinology.2023; 69(3): 103.     CrossRef
• Global estimates of rehabilitation needs and disease burden in tracheal, bronchus, and lung cancer from 1990 to 2019 and projections to 2045 based on the global burden of disease study 2019
  Xigui Lai, Conghui Li, Yao Yang, Mingyuan Niu, Yujie Yang, Shanshan Gu, Weiqian Hou, Lili Chen, Yi Zhu
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Social and racial inequalities in diabetes and cancer in the United States
  Nour Massouh, Ayad A. Jaffa, Hani Tamim, Miran A. Jaffa
  Frontiers in Public Health.2023;[Epub]     CrossRef
• Lactate in exhaled breath condensate and its correlation to cancer: challenges, promises and a call for data
  Veronika Ruzsányi, Miklós Péter Kalapos
  Journal of Breath Research.2023; 17(4): 044001.     CrossRef
• The impact of diabetes status on total and site-specific cancer risk in the elderly population: A nationwide cohort study
  Kyuho Kim, Bongseong Kim, Hyunho Kim, Hyung Soon Park, Yu-Bae Ahn, Seung-Hyun Ko, Kyungdo Han, Jae-Seung Yun
  Diabetes Research and Clinical Practice.2023; 203: 110866.     CrossRef
• Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
  Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
  Current Diabetes Reports.2023; 23(10): 253.     CrossRef
• PECAM-1 drives β-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus
  Qing Wu, Xingxing Du, Jianing Cheng, Xiuying Qi, Huan Liu, Xiaohong Lv, Xieyang Gong, Changxin Shao, Muhong Wang, Luxiao Yue, Xin Yang, Shiyu Li, Yafang Zhang, Xuemei Li, Huike Yang
  Cell Communication and Signaling.2023;[Epub]     CrossRef
• Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice
  Sabry M. Attia, Sheikh F. Ahmad, Ahmed Nadeem, Mohamed S.M. Attia, Mushtaq A. Ansari, Abdelkader E. Ashour, Norah A. Albekairi, Mohammed A. Al-Hamamah, Ali A. Alshamrani, Saleh A. Bakheet
  Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2023; 892: 503707.     CrossRef
• Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells
  Xiangyu Gao, Jiali Qian, Yang Zhang, Heming Wang, Jiefeng Cui, Yehong Yang
  Proteome Science.2023;[Epub]     CrossRef
• Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study
  Mia Scholten, Anders Halling, Kathleen Bennett
  PLOS ONE.2023; 18(10): e0292853.     CrossRef
• The interplay between antidiabetic medications and cancer risk
  Duaa Durrani, Muhammad Hassan, Aimen Zulfikar
  International Journal of Scientific Reports.2023; 9(11): 384.     CrossRef
• Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study
  Hui Gao, Shuhao Zheng, Xin Yuan, Jiarong Xie, Lei Xu
  BMC Medicine.2023;[Epub]     CrossRef
• Association between diabetes at different diagnostic ages and risk of cancer incidence and mortality: a cohort study
  Yu Peng, Fubin Liu, Peng Wang, Yating Qiao, Changyu Si, Xixuan Wang, Jianxiao Gong, Huijun Zhou, Fengju Song, Fangfang Song
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The Characteristics and Risk of Mortality in the Elderly Korean Population
  Sunghwan Suh
  Endocrinology and Metabolism.2023; 38(5): 522.     CrossRef
• Clinical potentials of metformin in cancer therapy
  Nidhi Sharma, Richa Dhingra
  Journal of Diabetology.2023; 14(4): 186.     CrossRef
• High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus
  Charupong Saengboonmee, Marutpong Detarya, Sakkarn Sangkhamanon, Kanlayanee Sawanyawisuth, Wunchana Seubwai, Sopit Wongkham
  Nutrition and Cancer.2022; 74(5): 1734.     CrossRef
• Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries
  Christoph Roderburg, Sven H. Loosen, Laura Hoyer, Tom Luedde, Karel Kostev
  Journal of Cancer Research and Clinical Oncology.2022; 148(5): 1057.     CrossRef
• Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
  Lara S. Lemon, Brian Orr, Francesmary Modugno, Ronald J. Buckanovich, Lan Coffman, Robert P. Edwards, Sarah Taylor
  Gynecologic Oncology.2022; 165(1): 60.     CrossRef
• The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
  Bing Zhu, Shen Qu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The impact of diabetes mellitus on levels of sex hormones and their receptors in tumor tissues in female rats with Guerin’s carcinoma
  E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, E. I. Surikova, Yu. A. Pogorelova, N. D. Cheryarina, I. M. Kotieva, M. I. Morozova, A. I. Shikhlyarova
  Research and Practical Medicine Journal.2022; 9(1): 23.     CrossRef
• Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study
  Oh. Hyeong Lee, Yong-Moon Park, Seung-Hyun Ko, Kyuna Lee, Yeonji Kim, Kyungdo Han, Jung-Hae Cho
  BMC Cancer.2022;[Epub]     CrossRef
• Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study
  Jing Ding, Xudong Li, Jun Ge, Yuanqian Gong, Ya Zhou, Juan Xiao, Qin Yang, Jing Chen, Mian Mao
  Cancer Management and Research.2022; Volume 14: 1313.     CrossRef
• The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients
  Xi-yu Liu
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1113.     CrossRef
• Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz
  Christian Jenssen, Cristine Pietsch
  Die Diabetologie.2022; 18(4): 379.     CrossRef
• Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
  Guotai Sheng, Dingyang Liu, Maobin Kuang, Yanjia Zhong, Shuhua Zhang, Yang Zou
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1677.     CrossRef
• The Association of Dietary Fiber Intake in Three Meals with All-Cause and Disease-Specific Mortality among Adults: The U.S. National Health and Nutrition Examination Survey, 2003–2014
  Jiayue Qi, Jian Gao, Yuntao Zhang, Wanying Hou, Tianshu Han, Changhao Sun
  Nutrients.2022; 14(12): 2521.     CrossRef
• A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
  Lin-Lin Cao, Yi Han, Lin Pei, Zhi-Hong Yue, Bo-Yu Liu, Jing-Wen Cui, Mei Jia, Hui Wang
  Metabolites.2022; 12(7): 610.     CrossRef
• Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
  Eun-Jung Rhee
  Endocrinology and Metabolism.2022; 37(3): 415.     CrossRef
• Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
  Endocrinology and Metabolism.2022; 37(3): 466.     CrossRef
• Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract
  Piero Portincasa, Leonilde Bonfrate, David Q.‐H. Wang, Gema Frühbeck, Gabriella Garruti, Agostino Di Ciaula
  European Journal of Clinical Investigation.2022;[Epub]     CrossRef
• Editorial: The relationship between diabetes and cancers and its underlying mechanisms
  Qiang Huo, Jing Wang, Nannan Zhang, Long Xie, Heshan Yu, Tao Li
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Oxidatively Damaged Nucleic Acid: Linking Diabetes and Cancer
  Xiujuan Hong, Yiqiu Hu, Zhijun Yuan, Zhihao Fang, Xiaoxiao Zhang, Ying Yuan, Cheng Guo
  Antioxidants & Redox Signaling.2022; 37(16-18): 1153.     CrossRef
• Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links
  Ya Wang, Xinling Zeng, Jie Tan, Yi Xu, Cunjian Yi
  Medicine.2022; 101(34): e30299.     CrossRef
• The Good, the Bad and the New about Uric Acid in Cancer
  Simone Allegrini, Mercedes Garcia-Gil, Rossana Pesi, Marcella Camici, Maria Grazia Tozzi
  Cancers.2022; 14(19): 4959.     CrossRef
• Family cancer history and smoking habit associated with sarcoma in a Japanese population study
  Yoshihiro Araki, Norio Yamamoto, Yoshikazu Tanzawa, Takahiro Higashi, Aya Kuchiba, Katsuhiro Hayashi, Akihiko Takeuchi, Shinji Miwa, Kentaro Igarashi, Makoto Endo, Eisuke Kobayashi, Hiroyuki Tsuchiya, Akira Kawai
  Scientific Reports.2022;[Epub]     CrossRef
• Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus
  Hehe Lv, Fan Zhang, Can Liang, Xuekui Liu, Yamei Ma, Jiayi Li, Yan Ye, Shanwen Si, Yaran Liu, Hao Heng, Houfa Geng
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Acute Pancreatitis Increases the Risk of Gastrointestinal Cancer in Type 2 Diabetic Patients: A Korean Nationwide Cohort Study
  Jin Ho Choi, Woo Hyun Paik, Dong Kee Jang, Min Kyu Kim, Ji Kon Ryu, Yong-Tae Kim, Kyungdo Han, Sang Hyub Lee
  Cancers.2022; 14(22): 5696.     CrossRef
• Targets for the prevention of comorbidity of cardiovascular and cancer diseases
  M. N. Mamedov, K. K. Badeinikova, A. K. Karimov
  Russian Journal of Cardiology.2022; 27(11): 5235.     CrossRef
• Prevalence and potential risk factors of self-reported diabetes among elderly people in China: A national cross-sectional study of 224,142 adults
  Xing Hu, Lingbing Meng, Zhimin Wei, Hongxuan Xu, Jianyi Li, Yingying Li, Na Jia, Hui Li, Xin Qi, Xuezhai Zeng, Qiuxia Zhang, Juan Li, Deping Liu
  Frontiers in Public Health.2022;[Epub]     CrossRef
• Urinary Exosomal Tissue TIMP and Angiopoietin-1 Are Preoperative Novel Biomarkers of Well-Differentiated Thyroid Cancer
  Chih-Yuan Wang, Shyang-Rong Shih, Kuen-Yuan Chen, Pei-Jie Huang
  Biomedicines.2022; 11(1): 24.     CrossRef
• Acquired and modifiable cardiovascular risk factors in patients treated for cancer
  Gary S. Beasley, Jeffrey A. Towbin
  Journal of Thrombosis and Thrombolysis.2021; 51(4): 846.     CrossRef
• Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products
  Wamidh H. Talib, Asma Ismail Mahmod, Sara Feras. Abuarab, Eliza Hasen, Amer A. Munaim, Shatha Khaled Haif, Amani Marwan Ayyash, Samar Khater, Intisar Hadi AL-Yasari, Lina T. Al Kury
  Molecules.2021; 26(8): 2179.     CrossRef
• Epidemiological link between obesity, type 2 diabetes mellitus and cancer
  Cornelius J Fernandez, Annu Susan George, Nikhila A Subrahmanyan, Joseph M Pappachan
  World Journal of Methodology.2021; 11(3): 23.     CrossRef
• Evaluation of the Efficacy of the Hospital Glycemic Management System for Patients with Malignant Tumors and Hyperglycemia
  Juan Jiang, Danlan Pu, Renzhi Hu, Mingyang Hu, Qinan Wu
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2717.     CrossRef
• Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
  Aldona Kasprzak
  International Journal of Molecular Sciences.2021; 22(12): 6434.     CrossRef
• TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
  Desh Deepak Singh, Dharmendra Kumar Yadav
  Biomedicines.2021; 9(8): 876.     CrossRef
• GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
  Xin Zhao, Minghe Wang, Zhitong Wen, Zhihong Lu, Lijuan Cui, Chao Fu, Huan Xue, Yunfeng Liu, Yi Zhang
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol
  Haruka Sudo, Akira Kubo
  International Journal of Molecular Sciences.2021; 22(17): 9397.     CrossRef
• EFFECT OF DIABETES MELLITUS ON THE LEVEL OF GROWTH FACTORS IN GUERIN CARCINOMA IN RATS OF BOTH SEXES
  E.M. Frantsiyants, V.A. Bandovkina, I.V. Kaplieva, E.I. Surikova, I.V. Neskubina, L.K. Trepitaki, N.D. Cheryarina, Yu.A. Pogorelova, L.A. Nemashkalova, A.I. Shikhlyarova, I.M. Kotieva, M.I. Morozova
  Ulyanovsk Medico-biological Journal.2021; : 129.     CrossRef
• Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS
  Miao Liu, Yu Liu, Hua Feng, Yixin Jing, Shuang Zhao, Shujia Yang, Nan Zhang, Shi Jin, Yafei Li, Mingjiao Weng, Xinzhu Xue, Fuya Wang, Yongheng Yang, Xiaoming Jin, Dan Kong
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Diabetes mellitus and cancer: a system of insulin-like growth factors
  E. M. Frantsiyants, E. I. Surikova, I. V. Kaplieva, V. A. Bandovkina, I. V. Neskubina, E. A. Sheiko, M. I. Morozova, I. M. Kotieva
  Problems of Endocrinology.2021; 67(5): 34.     CrossRef
• Diabetes and Cancer: Risk, Challenges, Management and Outcomes
  Rabia K. Shahid, Shahid Ahmed, Duc Le, Sunil Yadav
  Cancers.2021; 13(22): 5735.     CrossRef
• Obesity, Diabetes, and Increased Cancer Progression
  Dae-Seok Kim, Philipp E. Scherer
  Diabetes & Metabolism Journal.2021; 45(6): 799.     CrossRef
• Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
  Monika Kapszewicz, Ewa Małecka-Wojciesko
  Journal of Clinical Medicine.2021; 10(22): 5463.     CrossRef
• Chronic non-communicable diseases, risk factors, and quality of life in patients with malignancies of various localizations
  M.N. Mamedov, V.I. Potievskaya, E.K. Saribekyan, O.V. Pikin, D.V. Sidorov, Z.M. Salimov, V.A. Kutsenko, O.M. Drapkina
  Profilakticheskaya meditsina.2021; 24(11): 45.     CrossRef
• Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
  Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Esa Läärä
  Acta Oncologica.2020; 59(9): 1110.     CrossRef
• Transcriptional Profiling and Biological Pathway(s) Analysis of Type 2 Diabetes Mellitus in a Pakistani Population
  Zarish Noreen, Christopher A. Loffredo, Attya Bhatti, Jyothirmai J. Simhadri, Gail Nunlee-Bland, Thomas Nnanabu, Peter John, Jahangir S. Khan, Somiranjan Ghosh
  International Journal of Environmental Research and Public Health.2020; 17(16): 5866.     CrossRef
• Screening Strategy of Pancreatic Cancer in Patients with Diabetes Mellitus
  Suguru Mizuno, Yousuke Nakai, Kazunaga Ishigaki, Kei Saito, Hiroki Oyama, Tsuyoshi Hamada, Yukari Suzuki, Akiyuki Inokuma, Sachiko Kanai, Kensaku Noguchi, Tatsuya Sato, Ryunosuke Hakuta, Tomotaka Saito, Naminatsu Takahara, Hirofumi Kogure, Hiroyuki Isayam
  Diagnostics.2020; 10(8): 572.     CrossRef
• Changes in mortality rates and ratios in people with pharmacologically treated type 2 diabetes mellitus between 2001 and 2016 in Hungary
  György Jermendy, Zoltán Kiss, György Rokszin, Ibolya Fábián, István Wittmann, Péter Kempler
  Diabetes Research and Clinical Practice.2020; 163: 108134.     CrossRef

• Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target

  
  Lin Tang, Meng Xu, Long Zhang, Lin Qu, Xiaoyan Liu
  OncoTargets and Therapy.2020; Volume 13: 7411.     CrossRef
• Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study
  Jeong Mi Kim, Sang Soo Kim, In Joo Kim, Jong Ho Kim, Bo Hyun Kim, Mi Kyung Kim, Soon Hee Lee, Chang Won Lee, Min Chul Kim, Jun Hyeob Ahn, Jinmi Kim
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
  Kyle J. Gu, Guojun Li
  Journal of Cancer Prevention.2020; 25(3): 127.     CrossRef
• Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2
  Xueyan Zhou, Yinxue Xu, Di Yin, Feng Zhao, Zhixiang Hao, Ya’nan Zhong, Jingbo Zhang, Bei Zhang, Xiaoxing Yin
  Biomedicine & Pharmacotherapy.2020; 131: 110764.     CrossRef
• Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies
  Lihai Wang, Lei Zhong, Bin Xu, Min Chen, Hongxiao Huang
  BMJ Open.2020; 10(12): e040137.     CrossRef

Obesity results in an inflammatory microenvironment in adipose tissue, leading to the deterioration of tissue protective mechanisms. Although recent studies suggested the importance of type 2 immunity in an anti-inflammatory microenvironment in adipose tissue, the regulatory effects of T helper 2 (Th2) cytokines on systemic metabolic regulation are not fully understood. Recently, we identified the roles of the Th2 cytokine (interleukin 4 [IL-4] and IL-13)-induced adipokine, growth differentiation factor 15 (GDF15), in adipose tissue in regulating systemic glucose metabolism via signal transducer and activator of transcription 6 (STAT6) activation. Moreover, we showed that mitochondrial oxidative phosphorylation is required to maintain these macrophage-regulating autocrine and paracrine signaling pathways via Th2 cytokine-induced secretion of GDF15. In this review, we discuss how the type 2 immune response and Th2 cytokines regulate metabolism in adipose tissue. Specifically, we review the systemic regulatory roles of Th2 cytokines in metabolic disease and the role of mitochondria in maintenance of type 2 responses in adipose tissue homeostasis.

Citations

Citations to this article as recorded by  

• Orchestration of the Adipose Tissue Immune Landscape by Adipocytes
  David Bradley, Tuo Deng, Dharti Shantaram, Willa A. Hsueh
  Annual Review of Physiology.2024; 86(1): 199.     CrossRef
• Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease
  Balázs Bence Nyárády, Loretta Zsuzsa Kiss, Zsolt Bagyura, Béla Merkely, Edit Dósa, Orsolya Láng, László Kőhidai, Éva Pállinger
  Biomedicine & Pharmacotherapy.2024; 174: 116475.     CrossRef
• Evaluation of Mitochondrial Function in Blood Samples Shows Distinct Patterns in Subjects with Thyroid Carcinoma from Those with Hyperplasia
  Julia Bernal-Tirapo, María Teresa Bayo Jiménez, Pedro Yuste-García, Isabel Cordova, Ana Peñas, Francisco-Javier García-Borda, Cesar Quintela, Ignacio Prieto, Cristina Sánchez-Ramos, Eduardo Ferrero-Herrero, María Monsalve
  International Journal of Molecular Sciences.2023; 24(7): 6453.     CrossRef
• A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome
  Ronit Vogt Sionov, Ronit Ahdut-HaCohen
  Biomedicines.2023; 11(9): 2558.     CrossRef
• Gdf15 deletion exacerbates acute lung injuries induced by intratracheal inoculation of aerosolized ricin in mice
  Mengyun Deng, Duo Su, Nan Xiao, Zhipeng Zhang, Yifeng Wang, Fuliang Zong, Sha Li, Jinglin Wang, Dongsheng Zhou, Yuee Zhao, Huiying Yang
  Toxicology.2022; 469: 153135.     CrossRef
• Role of PPAR Receptor and Ligands in the Pathogenesis and Therapy of Hematologic Malignancies
  Jian Wu, Min Zhang, Allison Faircloth
  Hemato.2022; 3(3): 422.     CrossRef
• Macrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases
  Liwen Wang, Jie Hu, Haiyan Zhou
  The World Journal of Men's Health.2021; 39(4): 606.     CrossRef
• Th2 Cytokines Increase the Expression of Fibroblast Growth Factor 21 in the Liver
  Seul-Gi Kang, Seong-Eun Lee, Min-Jeong Choi, Joon-Young Chang, Jung-Tae Kim, Ben-Yuan Zhang, Yea-Eun Kang, Ju-Hee Lee, Hyon-Seung Yi, Minho Shong
  Cells.2021; 10(6): 1298.     CrossRef
• Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
  Jörg Wischhusen, Ignacio Melero, Wolf Herman Fridman
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages
  Irina Larionova, Elena Kazakova, Marina Patysheva, Julia Kzhyshkowska
  Cancers.2020; 12(6): 1411.     CrossRef

The link of diabetes with co-occurring disorders in the brain involves complex and multifactorial pathways. Genetically engineered rodents that express familial Alzheimer's disease-associated mutant forms of amyloid precursor protein and presenilin 1 (PSEN1) genes provided invaluable insights into the mechanisms and consequences of amyloid deposition in the brain. Adding diabetes factors (obesity, insulin impairment) to these animal models to predict success in translation to clinic have proven useful at some extent only. Here, we focus on contributing factors to diabetic brain injury with the aim of identifying appropriate animal models that can be used to mechanistically dissect the pathophysiology of diabetes-associated cognitive dysfunction and how diabetes medications may influence the development and progression of cognitive decline in humans with diabetes.

Citations

Citations to this article as recorded by  

• The association between renal accumulation of pancreatic amyloid-forming amylin and renal hypoxia
  Nirmal Verma, Florin Despa
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer’s disease
  Sweta Priyadarshini Pradhan, Pratap Kumar Sahu, Anindita Behera
  Molecular and Cellular Biochemistry.2023; 478(12): 2739.     CrossRef
• Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
  Jeimy Katherine Torres-Méndez, Julia Niño-Narvión, Patricia Martinez-Santos, Elena María Goretti Diarte-Añazco, Karen Alejandra Méndez-Lara, Tania Vázquez del Olmo, Noemi Rotllan, Maria Teresa Julián, Núria Alonso, Didac Mauricio, Mercedes Camacho, Juan P
  Nutrients.2023; 15(14): 3083.     CrossRef
• Ipriflavone as a non‐steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice
  Ruifang Nie, Jian Lu, Rui Xu, Juanzhen Yang, Xingyi Shen, Xingnan Ouyang, Danyang Zhu, Yujie Huang, Tong Zhao, Xuejian Zhao, Yin Lu, Minyi Qian, Jiaying Wang, Xu Shen
  Aging Cell.2022;[Epub]     CrossRef
• Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
  Geert Jan Biessels, Chloë Verhagen, Jolien Janssen, Esther van den Berg, Gudrun Wallenstein, Bernard Zinman, Mark A. Espeland, Odd Erik Johansen
  Diabetologia.2021; 64(6): 1235.     CrossRef
• The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
  Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol-Young Park
  Journal of Alzheimer's Disease.2021; 81(3): 1263.     CrossRef
• The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes
  Jinni Meng, Yafei Zhu, Huixia Ma, Xiaobo Wang, Qipeng Zhao
  Journal of Ethnopharmacology.2021; 280: 114464.     CrossRef
• Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef
• Diabetes and dementia – the two faces of Janus
  Athanasia Papazafiropoulou, Chris Koros, Andreas Melidonis , Stavros Antonopoulos
  Archives of Medical Science – Atherosclerotic Diseases.2020; 5(1): 186.     CrossRef

Mitochondrial function is crucial for the maintenance of cellular homeostasis under physiological and stress conditions. Thus, chronic exposure to environmental chemicals that affect mitochondrial function can have harmful effects on humans. We argue that the concept of hormesis should be revisited to explain the non-linear responses to mitochondrial toxins at a low-dose range and develop practical methods to protect humans from the negative effects of mitochondrial toxins. Of the most concern to humans are lipophilic chemical mixtures and heavy metals, owing to their physical properties. Even though these chemicals tend to demonstrate no safe level in humans, a non-linear dose-response has been also observed. Stress response activation, i.e., hormesis, can explain this non-linearity. Recently, hormesis has reemerged as a unifying concept because diverse stressors can induce similar stress responses. Besides potentially harmful environmental chemicals, healthy lifestyle interventions such as exercise, calorie restriction (especially glucose), cognitive stimulation, and phytochemical intake also activate stress responses. This conceptual link can lead to the development of practical methods that counterbalance the harm of mitochondrial toxins. Unlike chemical hormesis with its safety issues, the activation of stress responses via lifestyle modification can be safely used to combat the negative effects of mitochondrial toxins.

Citations

Citations to this article as recorded by  

• Rules of Heliogeomagnetics Diversely Coordinating Biological Rhythms and Promoting Human Health
  Kuniaki Otsuka, Germaine Cornelissen, Andi Weydahl, Denis Gubin, Larry A. Beaty, Masatoshi Murase
  Applied Sciences.2023; 13(2): 951.     CrossRef
• Can lipophilic pollutants in adipose tissue explain weight change‐related risk in type 2 diabetes mellitus?
  Duk‐Hee Lee, In‐Kyu Lee
  Journal of Diabetes Investigation.2023; 14(4): 528.     CrossRef
• Hormetic Effects of Cerium, Lanthanum and Their Combination at Sub-micromolar Concentrations in Sea Urchin Sperm
  Giovanni Pagano, Antonios Apostolos Brouziotis, Daniel Lyons, Ivana Čarapar, Rahime Oral, Serkan Tez, Philippe J. Thomas, Franca Tommasi, Giovanni Libralato, Marco Guida, Marco Trifuoggi
  Bulletin of Environmental Contamination and Toxicology.2023;[Epub]     CrossRef
• Mitochondria: It is all about energy
  Amaloha Casanova, Anne Wevers, Santiago Navarro-Ledesma, Leo Pruimboom
  Frontiers in Physiology.2023;[Epub]     CrossRef
• Type 2 Diabetes Induced by Changes in Proteomic Profiling of Zebrafish Chronically Exposed to a Mixture of Organochlorine Pesticides at Low Concentrations
  Yan Gao, Hyojin Lee, Sangkyu Lee, Ki-Tae Kim
  International Journal of Environmental Research and Public Health.2022; 19(9): 4991.     CrossRef
• Effect of Low-Dose Persistent Organic Pollutants on Mitochondrial Function: Human and in Vitro Evidence
  Se-A Kim, Hoyul Lee, Sung-Mi Park, Mi-Jin Kim, Yu-Mi Lee, Young-Ran Yoon, Hyun-Kyung Lee, Hyo-Bang Moon, In-Kyu Lee, Duk-Hee Lee
  Diabetes & Metabolism Journal.2022; 46(4): 592.     CrossRef
• Can Environmental Pollutants Be a Factor Linking Obesity and COVID-19?
  Duk-Hee Lee
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Intensive weight loss and cognition: The dynamics of persistent organic pollutants in adipose tissue can explain the unexpected results from the Action for Health in Diabetes (Look AHEAD) study
  Yu‐Mi Lee, Sun‐Hee Park, Duk‐Hee Lee
  Alzheimer's & Dementia.2020; 16(4): 696.     CrossRef
• Lipophilic Environmental Chemical Mixtures Released During Weight‐Loss: The Need to Consider Dynamics
  Duk‐Hee Lee, David R Jacobs, Lars Lind, P. Monica Lind
  BioEssays.2020;[Epub]     CrossRef
• Environmental toxicology and ecotoxicology: How clean is clean? Rethinking dose-response analysis
  Evgenios Agathokleous, Edward J. Calabrese
  Science of The Total Environment.2020; 746: 138769.     CrossRef

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

Citations

Citations to this article as recorded by  

• Serum-based ATR-FTIR spectroscopy combined with multivariate analysis for the diagnosis of pre-diabetes and diabetes
  Weiyi Pang, Yu Xing, Camilo L. M. Morais, Qiufeng Lao, Shengle Li, Zipeng Qiao, You Li, Maneesh N. Singh, Valério G. Barauna, Francis L. Martin, Zhiyong Zhang
  The Analyst.2024; 149(2): 497.     CrossRef
• Fruits and the Risk of Type 2 Diabetes: The Korean Genome and Epidemiology Study Cohort
  Hojun Yu, Cheol Min Lee, Seung-Won Oh
  Korean Journal of Family Medicine.2024; 45(1): 44.     CrossRef
• Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus
  Yesol Hong, Yoomin Jeon, Yoona Choi, Tae Kyu Chung, Howard Lee
  Diabetes Therapy.2024; 15(2): 487.     CrossRef
• Risk factors for carotid plaque formation in type 2 diabetes mellitus
  Jin Chen, Wenwen Li, Jingzhu Cao, Yuhan Lu, Chaoqun Wang, Jin Lu
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Cumulative exposure to impaired fasting glucose and gastrointestinal cancer risk: A nationwide cohort study
  Byeong Yun Ahn, Bokyung Kim, Sanghyun Park, Sang Gyun Kim, Kyungdo Han, Soo‐Jeong Cho
  Cancer.2024;[Epub]     CrossRef
• Effects of a Health Partnership Program Using Mobile Health Application for Male Workers with Cardiovascular Risk Factors in Small and Medium Enterprises: A Randomized Controlled Trial
  Eun Jin Kim, Seon Young Hwang
  Journal of Korean Academy of Nursing.2024; 54(1): 44.     CrossRef
• The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population
  Na Yeon Kim, Haekyung Lee, Sehee Kim, Ye-Jee Kim, Hyunsuk Lee, Junhyeong Lee, Soo Heon Kwak, Seunggeun Lee
  Scientific Reports.2024;[Epub]     CrossRef
• Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
  Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
  Advances in Therapy.2024;[Epub]     CrossRef
• The Potential Role of Presepsin in Predicting Severe Infection in Patients with Diabetic Foot Ulcers
  Eun Yeong Ha, Il Rae Park, Seung Min Chung, Young Nam Roh, Chul Hyun Park, Tae-Gon Kim, Woong Kim, Jun Sung Moon
  Journal of Clinical Medicine.2024; 13(8): 2311.     CrossRef
• Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
  Jaime A Davidson, Norlela Sukor, Fen‐Lee Hew, Mafauzy Mohamed, Zanariah Hussein
  Journal of Diabetes Investigation.2023; 14(2): 167.     CrossRef
• β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months
  Minyoung Lee, Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee
  Diabetes & Metabolism.2023; 49(4): 101427.     CrossRef
• Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
  Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
  Journal of Lipid and Atherosclerosis.2023; 12(1): 12.     CrossRef
• Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
  Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
  Diabetes & Metabolism Journal.2023; 47(1): 1.     CrossRef
• Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
  Min Kyong Moon, Junghyun Noh, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong
  Diabetes & Metabolism Journal.2023; 47(1): 45.     CrossRef
• Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
  Sejeong Lee, Jaehyun Bae, Doo Ri Jo, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Identifying the Associations of Nightly Fasting Duration and Meal Timing with Type 2 Diabetes Mellitus Using Data from the 2016–2020 Korea National Health and Nutrition Survey
  Junkyung Kwak, Kyeong-A Jang, Haeng-Ran Kim, Min-Sook Kang, Kyung Won Lee, Dayeon Shin
  Nutrients.2023; 15(6): 1385.     CrossRef
• Development and Adaptability of Smartphone-based Dietary Coaching Program for Patients Undergoing Diabetes and Prediabetes with Continuous Glucose Monitoring Device
  Myoung Soo Kim, Jung Mi Ryu, Minkyeong Kang, Jiwon Park, Yeh Chan Ahn, Yang Seok Kim
  Journal of Health Informatics and Statistics.2023; 48(1): 36.     CrossRef
• Glucose Control in Korean Patients with Type 2 Diabetes Mellitus according to Body Mass Index
  Ye-lim Shin, Heesoh Yoo, Joo Young Hong, Jooeun Kim, Kyung-do Han, Kyu-Na Lee, Yang-Hyun Kim
  Journal of Obesity & Metabolic Syndrome.2023; 32(1): 55.     CrossRef
• Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up
  Ji Young Kang, Kyungdo Han, Seung-Hwan Lee, Mee Kyoung Kim
  Respiratory Research.2023;[Epub]     CrossRef
• Developing a Classification Algorithm for Prediabetes Risk Detection From Home Care Nursing Notes
  Eunjoo Jeon, Aeri Kim, Jisoo Lee, Hyunsook Heo, Hana Lee, Kyungmi Woo
  CIN: Computers, Informatics, Nursing.2023; 41(7): 539.     CrossRef
• Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
  Yun Kyung Cho, Myungjin Kim, Ye-Jee Kim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study
  Gyu Bae Lee, Youn Huh, Sang Hyun Lee, Byoungduck Han, Yang-Hyun Kim, Do-Hoon Kim, Seon Mee Kim, Youn Seon Choi, Kyung Hwan Cho, Ga Eun Nam
  World Journal of Gastroenterology.2023; 29(45): 5962.     CrossRef
• Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes
  Han Na Jang, Ye Seul Yang, Tae Jung Oh, Bo Kyung Koo, Seong Ok Lee, Kyong Soo Park, Hak Chul Jang, Hye Seung Jung
  Journal of Diabetes Investigation.2022; 13(1): 85.     CrossRef
• Relationship between the early initiation of insulin treatment and diabetic complications in patients newly diagnosed with type 2 diabetes mellitus in Korea: A nationwide cohort study
  Ha‐Lim Jeon, Won Kim, Bongseong Kim, Ju‐Young Shin
  Journal of Diabetes Investigation.2022; 13(5): 830.     CrossRef
• Relationship of the Triglyceride-Glucose Index with Subclinical White Matter Hypersensitivities of Presumed Vascular Origin Among Community-Dwelling Koreans
  Dong-Hyuk Jung, Byoungjin Park, Yong-Jae Lee
  International Journal of General Medicine.2022; Volume 15: 603.     CrossRef
• Prevalence of vitamin B12 deficiency and its association with metformin-treated type 2 diabetic patients: A cross sectional study
  Shaimaa B. Almatrafi, El-Sayed H. Bakr, Asem A. Almatrafi, Manal M. Altayeb
  Human Nutrition & Metabolism.2022; 27: 200138.     CrossRef
• Retinal Vascular Caliber Changes in Early Type 2 Diabetic Patients without Retinopathy
  Jeong Woo Park, Jeong Hun Bae, Su Jeong Song, Joon Mo Kim
  Journal of the Korean Ophthalmological Society.2022; 63(1): 20.     CrossRef
• Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
  Hae Kyung Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Diabetes & Metabolism Journal.2022; 46(1): 104.     CrossRef
• Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
  Jae Hyun Bae, Chang Ho Ahn, Ye Seul Yang, Sun Joon Moon, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park, Young Min Cho
  Diabetes & Metabolism Journal.2022; 46(1): 71.     CrossRef
• Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition
  Dong Yoon Kang, Hyunah Kim, SooJeong Ko, HyungMin Kim, Jiwon Shinn, Min-Gyu Kang, Sun-ju Byeon, Jeong-Hee Choi, Soo-Yong Shin, Hun-Sung Kim
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus
  Ji Eun Han, Han-Bit Shin, Young Hwan Ahn, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun Kim
  Scientific Reports.2022;[Epub]     CrossRef
• Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
  Viswanathan Mohan, Banshi Saboo, Jabbar Khader, Kirtikumar D Modi, Sushil Jindal, Subhash Kumar Wangnoo, Sugumaran Amarnath
  Clinical Medicine Insights: Endocrinology and Diabetes.2022; 15: 117955142210746.     CrossRef
• Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model
  Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Sang Soo Kim, Eun-Hee Cho, Tae Sun Park
  Medicine.2022; 101(8): e28823.     CrossRef
• Atherogenic Index of Plasma and Its Association with Risk Factors of Coronary Artery Disease and Nutrient Intake in Korean Adult Men: The 2013–2014 KNHANES
  Hye Ran Shin, SuJin Song, Jin Ah Cho, Sun Yung Ly
  Nutrients.2022; 14(5): 1071.     CrossRef
• Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
  Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi
  Journal of Diabetes Investigation.2022; 13(6): 986.     CrossRef
• Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
  Liela Meng, Keun-Sang Kwon, Dae Jung Kim, Yong-ho Lee, Jeehyoung Kim, Abhijit V. Kshirsagar, Heejung Bang
  Diabetes & Metabolism Journal.2022; 46(2): 273.     CrossRef
• Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery
  Yeyoung Han, Gihyeon Kim, Eunyong Ahn, Sunhee Jung, Youngae Jung, Yunjae Kim, Eunyoung Ha, Yoonseok Heo, Do Hyun Ryu, Hansoo Park, Geum‐Sook Hwang
  Diabetes, Obesity and Metabolism.2022; 24(7): 1224.     CrossRef
• The use of complex marketing analysis and QSPR methodology for the necessity of a drug development grounding for the treatment of type 2 diabetes mellitus with increased bioavailability
  Inna Kovalevska, Olena Ruban, Alina Volkova, Alla Kotvitska, Alina Cherkashyna
  Pharmacia.2022; 69(2): 303.     CrossRef
• Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
  Sangmo Hong, Woo Je Lee, Cheol-Young Park
  Endocrinology and Metabolism.2022; 37(2): 233.     CrossRef
• Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients
  Won Seok Kim, Yonghoon Choi, Nayoung Kim, Seon Hee Lim, Gitark Noh, Ki Wook Kim, Jaehyung Park, Hyeongho Jo, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
  The Korean Journal of Internal Medicine.2022; 37(3): 579.     CrossRef
• Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
  Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
  Dae-Sung Kyoung, Hun-Sung Kim
  Journal of Lipid and Atherosclerosis.2022; 11(2): 103.     CrossRef
• Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study
  Si Hyoung Kim, Yun Kyung Cho, Ye-Jee Kim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park, Ji Hye Huh, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
  Cardiovascular Diabetology.2022;[Epub]     CrossRef
• Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
  Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sung
  Diabetes & Metabolism Journal.2022; 46(3): 464.     CrossRef
• Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
  Jaehyun Bae, Young-eun Kim, Minyoung Lee, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Yonsei Medical Journal.2022; 63(6): 539.     CrossRef
• Predictors for successful weight reduction during treatment with Dapagliflozin among patients with type 2 diabetes mellitus in primary care
  Youn Huh, Young Sik Kim
  BMC Primary Care.2022;[Epub]     CrossRef
• Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
  Xiao-Ying Li, Li Li, Sang-Hoon Na, Francesca Santilli, Zhongwei Shi, Michael Blaha
  American Journal of Preventive Cardiology.2022; 11: 100363.     CrossRef
• Factors Influencing the Utilization of Diabetes Complication Tests Under the COVID-19 Pandemic: Machine Learning Approach
  Haewon Byeon
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes
  Mee Kyoung Kim, Kyungdo Han, Bongsung Kim, Jinyoung Kim, Hyuk-Sang Kwon
  Scientific Reports.2022;[Epub]     CrossRef
• Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
  Endocrinology and Metabolism.2022; 37(3): 466.     CrossRef
• Analysis of Continuity of Care and Its Related Factors in Diabetic Patients: A Cross-Sectional Study
  Ji Yeh Shin, Ha Jin Kim, BeLong Cho, Yun Jun Yang, Jae Moon Yun
  Korean Journal of Family Medicine.2022; 43(4): 246.     CrossRef
• Development of Various Diabetes Prediction Models Using Machine Learning Techniques
  Juyoung Shin, Jaewon Kim, Chanjung Lee, Joon Young Yoon, Seyeon Kim, Seungjae Song, Hun-Sung Kim
  Diabetes & Metabolism Journal.2022; 46(4): 650.     CrossRef
• A causal relationship between alcohol intake and type 2 diabetes mellitus: A two-sample Mendelian randomization study
  Meiling Liu, Sunmin Park
  Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(12): 2865.     CrossRef
• Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia
  Seong Ho Kim, Ji Young Kim, Eun Song Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Annals of Medicine.2022; 54(1): 2724.     CrossRef
• Association of the Estimated Pulse Wave Velocity with Cardio-Vascular Disease Outcomes among Men and Women Aged 40–69 Years in the Korean Population: An 18-Year Follow-Up Report on the Ansung–Ansan Cohort in the Korean Genome Environment Study
  Byung Sik Kim, Yonggu Lee, Jin-Kyu Park, Young-Hyo Lim, Jeong-Hun Shin
  Journal of Personalized Medicine.2022; 12(10): 1611.     CrossRef
• Perfluorinated compounds in adults and their association with fasting glucose and incident diabetes: a prospective cohort study
  Seung Min Chung, Dong-Gyu Heo, Ju-Hyun Kim, Ji Sung Yoon, Hyoung Woo Lee, Jong-Yeon Kim, Jun Sung Moon, Kyu Chang Won
  Environmental Health.2022;[Epub]     CrossRef
• Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
  Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
  Frontiers in Public Health.2022;[Epub]     CrossRef
• Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness
  Juyoung Shin, Joonyub Lee, Taehoon Ko, Kanghyuck Lee, Yera Choi, Hun-Sung Kim
  Journal of Personalized Medicine.2022; 12(11): 1899.     CrossRef
• Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?
  Jeongmin Lee, Min-Hee Kim, Jung-Min Lee, Sang-Ah Chang
  Journal of Clinical Medicine.2022; 11(22): 6756.     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors
  Jianhua Ma, Bin Zhang, Jianing Hou, Yongde Peng
  Diabetes Therapy.2021; 12(1): 211.     CrossRef
• Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: AnEast Asianperspective
  Linong Ji, Juliana C. N. Chan, Miao Yu, Kun Ho Yoon, Sin Gon Kim, Sung Hee Choi, Chien‐Ning Huang, Shih Te Tu, Chih‐Yuan Wang, Päivi Maria Paldánius, Wayne H. H. Sheu
  Diabetes, Obesity and Metabolism.2021; 23(1): 3.     CrossRef
• Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study
  Seung Jin Han, Kyoung Hwa Ha, Nami Lee, Dae Jung Kim
  Diabetes, Obesity and Metabolism.2021; 23(3): 682.     CrossRef
• Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an International Expert Group (South Asia, Middle East & Africa) via modified Delphi method
  Sanjay Kalra, Das A. K., Fariduddin Md., Shaikh K., Shah P., Rehim A. A., John M., Shaikh S., Orabi A., Saraswati M. R., Shahjada Selim, Baruah M. P., K. K. Gangopadhyay, Langi Y. A., Nair T., Dhanwal D., Thapa S. D., Deshmukh V., D. Dutta, Khalfan H., Ma
  Current Medical Research and Opinion.2021; 37(3): 403.     CrossRef
• The association between lipoprotein (a) and carotid atherosclerosis in patients with type 2 diabetes without pre-existing cardiovascular disease: A cross-sectional study
  Ji Eun Jun, Hongsun Kang, You-Cheol Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, In-Kyung Jeong
  Diabetes Research and Clinical Practice.2021; 171: 108622.     CrossRef
• Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
  Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef
• Effect of Tai Chi on Quality of Life, Body Mass Index, and Waist-Hip Ratio in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  Jiawei Qin, Yannan Chen, Shuai Guo, Yue You, Ying Xu, Jingsong Wu, Zhizhen Liu, Jia Huang, Lidian Chen, Jing Tao
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
  Soo-Yeon Choi, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2021; 36(2): 263.     CrossRef
• Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
  Chan-Hee Jung, Jang Won Son, Shinae Kang, Won Jun Kim, Hun-Sung Kim, Hae Soon Kim, Mihae Seo, Hye-Jung Shin, Seong-Su Lee, Su Jin Jeong, Yongin Cho, Seung Jin Han, Hyang Mi Jang, Mira Rho, Shinbi Lee, Mihyun Koo, Been Yoo, Jung-Wha Moon, Hye Young Lee, Ja
  Diabetes & Metabolism Journal.2021; 45(1): 1.     CrossRef
• Estimation of sodium‐glucose cotransporter 2 inhibitor–related genital and urinary tract infections via electronic medical record–based common data model
  SooJeong Ko, HyungMin Kim, Jiwon Shinn, Sun‐ju Byeon, Jeong‐Hee Choi, Hun‐Sung Kim
  Journal of Clinical Pharmacy and Therapeutics.2021; 46(4): 975.     CrossRef
• Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study
  Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
  Drug Design, Development and Therapy.2021; Volume 15: 651.     CrossRef
• Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
  Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Hyung-Wook Kim, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko
  Scientific Reports.2021;[Epub]     CrossRef
• Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes
  Han Ul Kim, Sung Pyo Park, Yong-Kyu Kim
  Scientific Reports.2021;[Epub]     CrossRef
• Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
  Jin-Hee Lee, Suk Chon, Seon-Ah Cha, Sun-Young Lim, Kook-Rye Kim, Jae-Seung Yun, Sang Youl Rhee, Kun-Ho Yoon, Yu-Bae Ahn, Jeong-Taek Woo, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2021; 36(2): 382.     CrossRef
• Simple Sugar Intake in Diabetics and Non-Diabetic Patients Who Visit Primary Care Clinic
  Seo Young Park, Geun Bae Moon, Young Sik Kim, Seung Hee Kim
  Korean Journal of Family Practice.2021; 11(1): 29.     CrossRef
• Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
  Da Hea Seo, Kyoung Hwa Ha, So Hun Kim, Dae Jung Kim
  Endocrinology and Metabolism.2021; 36(1): 70.     CrossRef
• Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020
  Eun-Jung Rhee, Mee-Kyung Kim, Won-Young Lee
  Endocrinology and Metabolism.2021; 36(1): 41.     CrossRef
• Factors Associated with Poor Glycemic Control Amongst Rural Residents with Diabetes in Korea
  Junhee Ahn, Youngran Yang
  Healthcare.2021; 9(4): 391.     CrossRef
• Diabetes and Stroke
  Junghyun Noh
  The Journal of Korean Diabetes.2021; 22(1): 26.     CrossRef
• Epidemiology of cardiovascular disease and its risk factors in Korea
  Hyeon Chang Kim
  Global Health & Medicine.2021; 3(3): 134.     CrossRef
• Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus
  Mee Kyoung Kim, Kyungdo Han, Eun Sil Koh, Oak-Kee Hong, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Diabetes Research and Clinical Practice.2021; 175: 108799.     CrossRef
• No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
  Yu Kyong Kim, Jun Gi Hwang, Min Kyu Park
  Drug Design, Development and Therapy.2021; Volume 15: 1725.     CrossRef
• Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Endocrinology and Metabolism.2021; 36(2): 388.     CrossRef
• The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
  Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol-Young Park
  Journal of Alzheimer's Disease.2021; 81(3): 1263.     CrossRef
• Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial
  Eun-Young Lee, Jae-Seung Yun, Seon-Ah Cha, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Seung-Hyun Ko
  International Journal of Environmental Research and Public Health.2021; 18(10): 5300.     CrossRef
• Cerium Oxide Nanoparticle-Containing Colorimetric Contact Lenses for Noninvasively Monitoring Human Tear Glucose
  Sijin Park, Juil Hwang, Hee-Jae Jeon, Woo Ri Bae, In-Kyung Jeong, Tae Gi Kim, Jaheon Kang, Young-Geun Han, Euiheon Chung, Dong Yun Lee
  ACS Applied Nano Materials.2021; 4(5): 5198.     CrossRef
• Low nutritional status links to the prevalence of pre-metabolic syndrome and its cluster in metabolically high-risk Korean adults
  Jieun Kim, Kyoungsik Jeong, Siwoo Lee, Bok-Nam Seo, Younghwa Baek
  Medicine.2021; 100(20): e25905.     CrossRef
• Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status
  Dongsub Jeon, Minkook Son, Juhyun Shim
  Nutrients.2021; 13(5): 1720.     CrossRef
• Classification and Prediction on the Effects of Nutritional Intake on Overweight/Obesity, Dyslipidemia, Hypertension and Type 2 Diabetes Mellitus Using Deep Learning Model: 4–7th Korea National Health and Nutrition Examination Survey
  Hyerim Kim, Dong Hoon Lim, Yoona Kim
  International Journal of Environmental Research and Public Health.2021; 18(11): 5597.     CrossRef
• Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies
  Linong Ji, Yan Bi, Shandong Ye, Yun Huang, Xia Zhang, Shuhua Shang, Nan Cui, Huiqiu Yin, Minlu Zhang
  Diabetes Research and Clinical Practice.2021; 176: 108848.     CrossRef
• Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
  Ahmed Arafa, Hyeok-Hee Lee, Ehab S. Eshak, Kokoro Shirai, Keyang Liu, Jiaqi Li, Naharin Sultana Anni, Sun Young Shim, Hyeon Chang Kim, Hiroyasu Iso
  Korean Circulation Journal.2021; 51(8): 643.     CrossRef
• Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
  Won Euh, Soo Lim, Jin-Wook Kim
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Effect of serum isoniazid level on treatment outcomes among tuberculosis patients with slow response – A retrospective cohort study
  Hyung Woo Kim, Ah Young Shin, Jick Hwan Ha, Joong Hyun Ahn, Hye Seon Kang, Ju Sang Kim
  Journal of Infection and Chemotherapy.2021; 27(11): 1555.     CrossRef
• Recent Perspective of Metformin
  Sangmo Hong
  The Journal of Korean Diabetes.2021; 22(2): 85.     CrossRef
• Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
  Awadhesh K Singh, Ritu Singh, Partha Pratim Chakraborty
  International Journal of General Medicine.2021; Volume 14: 3833.     CrossRef
• The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes
  Jihyun Yoon, Donghyuk Jung, Yongjae Lee, Byoungjin Park
  Journal of Personalized Medicine.2021; 11(8): 742.     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
  Ja Young Jeon
  Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
• 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
  Kyu Yeon Hur, Min Kyong Moon, Jong Suk Park, Soo-Kyung Kim, Seung-Hwan Lee, Jae-Seung Yun, Jong Ha Baek, Junghyun Noh, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Ye Seul Yang, Jang Won Son, Jong Han Choi, Kee Ho Song, Nam Hoon Kim, Sang Yong Kim, Jin Wha Kim,
  Diabetes & Metabolism Journal.2021; 45(4): 461.     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
  Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, Kyeong Jin Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2021; 45(4): 617.     CrossRef
• Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical Data in Korea
  Kyuho Kim, Sung Hee Choi
  Diabetes & Metabolism Journal.2021; 45(4): 502.     CrossRef
• The Effects of Dietary Education Interventions on Individuals with Type 2 Diabetes: A Systematic Review and Meta-Analysis
  Juri Kim, Myung-Haeng Hur
  International Journal of Environmental Research and Public Health.2021; 18(16): 8439.     CrossRef
• Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
  Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
  Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
  Jeonghoon Ha, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Seung Hyun Ko, Moo Il Kang, Sung Dae Moon, Ki-Hyun Baek
  Endocrinology and Metabolism.2021; 36(4): 895.     CrossRef
• Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
  Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
  Endocrinology and Metabolism.2021; 36(4): 823.     CrossRef
• High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study
  Sung-Woo Kim, Jae-Han Jeon, Jun Sung Moon, Mi Kyung Kim
  Endocrinology and Metabolism.2021; 36(4): 800.     CrossRef
• Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans
  Julie J. Kim, Jihyun Yoon, Yong-Jae Lee, Byoungjin Park, Dong-Hyuk Jung
  Nutrients.2021; 13(9): 3231.     CrossRef
• Quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for type 2 diabetes mellitus: A systematic review
  Jeremy Y. Ng, Kiran D. Verma, Kevin Gilotra
  Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(11): 3004.     CrossRef
• Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea
  Hyuk Sang Kwon, Kee Ho Song, Jae Myung Yu, Dong Sun Kim, Ho Sang Shon, Kyu Jeung Ahn, Sung Hee Choi, Seung Hyun Ko, Won Kim, Kyoung Hwa Lee, Il Seong Nam-Goong, Tae Sun Park
  Journal of Obesity & Metabolic Syndrome.2021; 30(3): 261.     CrossRef
• Frequency of Exposure to Impaired Fasting Glucose and Risk of Mortality and Cardiovascular Outcomes
  Seung-Hwan Lee, Kyungdo Han, Hyuk-Sang Kwon, Mee Kyoung Kim
  Endocrinology and Metabolism.2021; 36(5): 1007.     CrossRef
• How Can We Adopt the Glucose Tolerance Test to Facilitate Predicting Pregnancy Outcome in Gestational Diabetes Mellitus?
  Kyeong Jin Kim, Nam Hoon Kim, Jimi Choi, Sin Gon Kim, Kyung Ju Lee
  Endocrinology and Metabolism.2021; 36(5): 988.     CrossRef
• Symptom Clusters and Quality of Life in Patients with Type 2 Diabetes Mellitus
  Su-Yeon Hong, Yang-Sook Yoo
  Korean Journal of Adult Nursing.2021; 33(5): 498.     CrossRef
• Long-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study
  Eu Jeong Ku, Dong-Hwa Lee, Hyun Jeong Jeon, Tae Keun Oh
  Diabetes Research and Clinical Practice.2021; 182: 109123.     CrossRef
• Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes
  Jaekyung Bae, Ji-Hyung Yoon, Jung-Hee Lee, Jong-Ho Nam, Chan-Hee Lee, Jang-Won Son, Ung Kim, Jong-Seon Park, Dong-Gu Shin
  The Korean Journal of Internal Medicine.2021; 36(6): 1365.     CrossRef
• Role of Leptin with hypothyroidism in Iraqi diabetic type 2 patients
  Sulaiman M. Hasan
  Bionatura.2021; 6(4): 2274.     CrossRef
• Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data
  Hong Ki Min, Se Hee Kim, Jong Han Choi, Kyomin Choi, Hae-Rim Kim, Sang-Heon Lee
  World Journal of Clinical Cases.2021; 9(33): 10198.     CrossRef
• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Comparisons of Neuropsychological Characteristics of Elderly Subjects With Versus Without History of Agent Orange Exposure
  Seunggyu Han, Jinhee Choi, Hyung Seok So, Hayun Choi, Hong Jin Jeon, Jinseob Kim, Kiwon Kim
  Journal of Korean Neuropsychiatric Association.2021; 60(4): 346.     CrossRef
• Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
  Hae Kyung Kim, Minyoung Lee, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
  Min Ho Kim, Hyung Jung Oh, Soon Hyo Kwon, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Hyoungnae Kim, Dong-Ryeol Ryu
  Kidney Research and Clinical Practice.2021; 40(4): 660.     CrossRef
• Sleep Duration and Its Associations with Mortality and Quality of Life in Chronic Obstructive Pulmonary Disease: Results from the 2007–2015 KNAHNES
  So Jeong Kim, Nakwon Kwak, Sun Mi Choi, Jinwoo Lee, Young Sik Park, Chang-Hoon Lee, Sang-Min Lee, Chul-Gyu Yoo, Jaeyoung Cho
  Respiration.2021; 100(11): 1043.     CrossRef
• Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
  Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
  Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
• Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design
  Sera Lee, Miyoung Ock, Hun‐Sung Kim, Hyunah Kim
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2020; 40(9): 902.     CrossRef
• Diabetic kidney disease: seven questions
  Dong Ho Yang, So-Young Lee
  Journal of the Korean Medical Association.2020; 63(1): 6.     CrossRef
• Diabetes and Metabolism Journal in 2020: Good to Great
  In-Kyung Jeong
  Diabetes & Metabolism Journal.2020; 44(1): 1.     CrossRef
• The Use of Mobile Personal Health Records for Hemoglobin A1c Regulation in Patients With Diabetes: Retrospective Observational Study
  Dongjin Seo, Yu Rang Park, Yura Lee, Ji Young Kim, Joong-Yeol Park, Jae-Ho Lee
  Journal of Medical Internet Research.2020; 22(6): e15372.     CrossRef
• Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy
  Kyung Ae Lee, Tae Sun Park, Heung Yong Jin
  Endocrine.2020; 70(3): 465.     CrossRef
• An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men
  Seol Ju Moon, Kyung-Sang Yu, Min-Gul Kim
  Clinical Therapeutics.2020; 42(6): 1047.     CrossRef
• The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
  Mi Kyung Kim, Jae-Han Jeon, Sung-Woo Kim, Jun Sung Moon, Nan Hee Cho, Eugene Han, Ji Hong You, Ji Yeon Lee, Miri Hyun, Jae Seok Park, Yong Shik Kwon, Yeon-Kyung Choi, Ki Tae Kwon, Shin Yup Lee, Eon Ju Jeon, Jin-Woo Kim, Hyo-Lim Hong, Hyun Hee Kwon, Chi Yo
  Diabetes & Metabolism Journal.2020; 44(4): 602.     CrossRef
• The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
  Seung Min Chung, Yin Young Lee, Eunyeong Ha, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee, Jian Hur, Kyung Soo Hong, Jong Geol Jang, Hyun Jung Jin, Eun Young Choi, Kyeong-Cheol Shin, Jin Hong Chung, Kwan Ho Lee, June Hong Ahn, Jun Sung Moon
  Diabetes & Metabolism Journal.2020; 44(3): 405.     CrossRef
• A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea
  Mee-Kyoung Kim, Kyungdo Han, Jae-Hyoung Cho, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
  Diabetes Research and Clinical Practice.2020; 163: 108157.     CrossRef
• Effects of Cardiovascular Risk Factor Variability on Health Outcomes
  Seung-Hwan Lee, Mee Kyoung Kim, Eun-Jung Rhee
  Endocrinology and Metabolism.2020; 35(2): 217.     CrossRef
• Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
  Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon
  Diabetes & Metabolism Journal.2020; 44(4): 489.     CrossRef
• Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
  Kyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, Miyeun Han, Dong Won Lee, Hyuk-Sang Kwon
  Diabetes & Metabolism Journal.2020; 44(1): 3.     CrossRef
• Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
  Eun-Jung Rhee
  Endocrinology and Metabolism.2020; 35(1): 85.     CrossRef
• Using adult stem cells to monitor endothelial dysfunction in diabetes mellitus
  Rohit Jain, Hassan Awal, Sabyasachi Sen
  Journal of Diabetes and its Complications.2020; 34(7): 107588.     CrossRef
• Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction
  Nam Hoon Kim, Sin Gon Kim
  Diabetes & Metabolism Journal.2020; 44(2): 213.     CrossRef
• Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
  Kyu Yeon Hur, Mee Kyoung Kim, Seung Hyun Ko, Miyeun Han, Dong Won Lee, Hyuk-Sang Kwon
  Kidney Research and Clinical Practice.2020; 39(1): 32.     CrossRef
• Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control
  Min Jung Kim, Eun Young Lee, Young-Hye You, Hae Kyung Yang, Kun-Ho Yoon, Ji-Won Kim
  Stem Cell Research.2020; 48: 101958.     CrossRef
• Glucose-Lowering Effect of Home-Delivered Therapeutic Meals in Patients with Type 2 Diabetes
  Jong Han Choi, Se Hee Min, Kyeong Hye Lim, Uoon Jeong Shin, Min-Seon Kim
  The Journal of Korean Diabetes.2020; 21(1): 46.     CrossRef
• Subclinical thyroid dysfunction in the first trimester of pregnancy: ‘Disease’ versus physiological (pulsatile) variation in TSH concentrations
  Krzysztof C. Lewandowski, Karolina Garnysz, Wojciech Horzelski, Joanna Kawalec, Karolina Budzen, Mariusz Grzesiak, Andrzej Lewinski
  Clinical Endocrinology.2020; 93(6): 739.     CrossRef
• Usefulness of carotid ultrasonography and treatment of carotid disease
  Seung Min Kim, Yeon Jung Kim, Keonwoo Kim, Bum Joon Kim
  Journal of the Korean Medical Association.2020; 63(6): 342.     CrossRef
• Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
  Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
  International Journal of Endocrinology.2020; 2020: 1.     CrossRef
• Prepregnancy smoking and the risk of gestational diabetes requiring insulin therapy
  Mee Kyoung Kim, Kyungdo Han, Sang Youn You, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
  Scientific Reports.2020;[Epub]     CrossRef
• Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
  Wayne Huey-Herng Sheu, Siew Pheng Chan, Bien J. Matawaran, Chaicharn Deerochanawong, Ambrish Mithal, Juliana Chan, Ketut Suastika, Chin Meng Khoo, Huu Man Nguyen, Ji Linong, Andrea Luk, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2020; 44(1): 11.     CrossRef
• Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405–13)
  Seung Min Chung, June Hong Ahn, Jun Sung Moon
  Diabetes & Metabolism Journal.2020; 44(4): 625.     CrossRef
• Effect of roux-en Y gastric bypass surgery on patients with type 2 diabetes mellitus
  Ke-Yan Chen, Ying-Li Liu, Jin-Cai Shang, De-Wang Su, Rong-Rong Yao, De-Zhi Ke, Hao Tian
  Medicine.2020; 99(23): e20382.     CrossRef
• Comparison and Implication of the Contemporary Blood Pressure Guidelines on Korean Population
  So Mi Jemma Cho, Hokyou Lee, Hyeon Chang Kim
  Korean Circulation Journal.2020; 50(6): 485.     CrossRef
• Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)
  Gyuri Kim, Soo Lim, Hyuk‐Sang Kwon, Ie B. Park, Kyu J. Ahn, Cheol‐Young Park, Su K. Kwon, Hye S. Kim, Seok W. Park, Sin G. Kim, Min K. Moon, Eun S. Kim, Choon H. Chung, Kang S. Park, Mikyung Kim, Dong J. Chung, Chang B. Lee, Tae H. Kim, Moon‐Kyu Lee
  Diabetes, Obesity and Metabolism.2020; 22(9): 1527.     CrossRef
• Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
  Kyung-Soo Kim, Byung-Wan Lee
  Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef
• Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
  Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
  Endocrinology and Metabolism.2020; 35(3): 636.     CrossRef
• Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study
  Min Cheol Chang, Jong-Moon Hwang, Jae-Han Jeon, Sang Gyu Kwak, Donghwi Park, Jun Sung Moon
  Endocrinology and Metabolism.2020; 35(3): 595.     CrossRef
• Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
  Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon
  Kidney Research and Clinical Practice.2020; 39(3): 269.     CrossRef
• Dynamic changes in nocturnal blood glucose levels are associated with sleep-related features in patients with obstructive sleep apnea
  Jung-Ick Byun, Kwang Su Cha, Ji Eun Jun, Tae-Joon Kim, Ki-Young Jung, In-Kyung Jeong, Won Chul Shin
  Scientific Reports.2020;[Epub]     CrossRef

• Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus

  
  Eugene Han, Minyoung Lee, Yong-ho Lee, Hye Soon Kim, Byung-wan Lee, Bong-Soo Cha, Eun Seok Kang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4113.     CrossRef
• A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study)
  Eun Heui Kim, Sang Soo Kim, Dong Jun Kim, Young Sik Choi, Chang Won Lee, Bon Jeong Ku, Kwang Soo Cha, Kee Ho Song, Dae Kyeong Kim, In Joo Kim
  Scientific Reports.2020;[Epub]     CrossRef
• Effect of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Weight on Emergency Hospitalization and 30‐Day Mortality in the General Population
  Seung‐Hwan Lee, Kyungdo Han, Hyuk‐Sang Kwon, Kun‐Ho Yoon, Mee Kyoung Kim
  Journal of the American Heart Association.2020;[Epub]     CrossRef
• Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management
  Aisling Smyth, Mark Jenkins, Melissa Dunham, Yvonne Kutzer, Shahrad Taheri, Lisa Whitehead
  Diabetes Research and Clinical Practice.2020; 170: 108532.     CrossRef
• The risk factors for treatment-related mortality within first three months after kidney transplantation
  Ye Na Kim, Do Hyoung Kim, Ho Sik Shin, Sangjin Lee, Nuri Lee, Min-Jeong Park, Wonkeun Song, Seri Jeong, Robert Jeenchen Chen
  PLOS ONE.2020; 15(12): e0243586.     CrossRef
• The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study
  Sangmo Hong, Kyungdo Han, Cheol-Young Park
  BMC Medicine.2020;[Epub]     CrossRef
• The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data
  Byoungjin Park, Yong-Jae Lee, Hye Sun Lee, Dong-Hyuk Jung
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Increased Age of Death and Change in Causes of Death Among Persons With Diabetes Mellitus From the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
  SSRN Electronic Journal .2020;[Epub]     CrossRef
• Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
  Jun Sung Moon
  Diabetes & Metabolism Journal.2019; 43(6): 911.     CrossRef
• Differences in prevalence of hypertension subtypes according to the 2018 Korean Society of Hypertension and 2017 American College of Cardiology/American Heart Association guidelines: The Korean National Health and Nutrition Examination Survey, 2007–2017 (
  So Mi Jemma Cho, Hokyou Lee, Hyeon Chang Kim
  Clinical Hypertension.2019;[Epub]     CrossRef
• Adult Stem Cells: Beyond Regenerative Tool, More as a Bio-Marker in Obesity and Diabetes
  Sabyasachi Sen
  Diabetes & Metabolism Journal.2019; 43(6): 744.     CrossRef
• Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease
  Mee Kyoung Kim, Kyungdo Han, Han Na Joung, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Management of Cardiovascular Risk Factors in Elderly Diabetes Mellitus Patients
  Sung Hoon Yu
  The Journal of Korean Diabetes.2019; 20(4): 233.     CrossRef
• Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2019;43:582–9)
  Tae Seo Sohn
  Diabetes & Metabolism Journal.2019; 43(6): 909.     CrossRef
• An Age of Sodium-Glucose Cotransporter-2 Inhibitor Priority: Are We Ready?
  Ji A Seo
  Diabetes & Metabolism Journal.2019; 43(5): 578.     CrossRef
• Association between Diabetes and the Use of Removable Dental Prostheses among the Korean Population
  Jae-Hyun Lee, Jung-Suk Han, Kyungdo Han, Su-Young Lee
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Metabolic Surgery and Diabetes Mellitus: Its Effects and Side Effects
  Mee Kyoung Kim
  The Journal of Korean Diabetes.2019; 20(4): 205.     CrossRef